Literatura | 2015 | 2014 | 2013 |

Notas de Interés | 2013 |

TAP picks 2016

Literatura y publicaciones recomendadas para los investigadores que trabajan en temas relacionados con el cáncer, en especial el cáncer de mama. Tus sugerencias serán recibidas en: contacto@tomateloapecho.org.mx

 

 

Diciembre

  • Rulla M. Tamimi, Donna Spiegelman, Stephanie A. Smith-Warner, Molin Wang, Mathew Pazaris, Walter C. Willett, A. Heather Eliassen, and David J. Hunter. Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer
    Am. J. Epidemiol.  2016, doi:10.1093/aje/kww145
    http://bit.ly/2hq0kJG
  • News. Michael McCarthy. Cancer drugs remain FDA approved despite lack of benefit, study finds
    BMJ 2016; 355 doi: http://dx.doi.org/10.1136/bmj.i6568
    http://bit.ly/2hfDIZ7
  • J.W. Lim, E.J. Shon and E.J. Yang. A qualitative study of healthcare providers’ perceptions and suggestions for developing cancer survivorship care models in South Korea. Eur J Cancer Care 2016, DOI: 10.1111/ecc.12613
    http://bit.ly/2hgDtQe
  • Carsten Denkert, Cornelia Liedtke, Andrew Tutt, Gunter von Minckwitz. Molecular alterations in triple-negative breast cancer—the road to new treatment strategies. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)32454-0
    http://bit.ly/2gMEmfK
  • Sibylle Loibl, Luca Gianni. HER2-positive breast cancer. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)32417-5
    http://bit.ly/2hgHHY4
  • Nicholas C Turner, Patrick Neven, Sibylle Loibl, Fabrice Andre. Advances in the treatment of advanced oestrogen-receptor-positive breast cancer. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)32419-9
    http://bit.ly/2hy2djq
  • PERSPECTIVE. James T. Topham, Marco A. Marra. Sequencing Strategies to Guide Decision Making in Cancer Treatment. Plos medicine 2016 http://dx.doi.org/10.1371/journal.pmed.1002189
    http://bit.ly/2glM1AK
  • PERSPECTIVE.  Francisco Beca, Andrew H. Beck. Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials. Plos Medicine 2016, http://dx.doi.org/10.1371/journal.pmed.1002177
    http://bit.ly/2gwU29y
  • Comment. Leclerc, AF., Jerusalem, G., Devos, M. et al. Multidisciplinary management of breast cancer. Arch Public Health (2016) 74: 50. doi:10.1186/s13690-016-0163-7
    http://bit.ly/2hgVQV9
  • Harry B. Burke. Improving the safety and quality of cancer care. Cancer 2016, DOI: 10.1002/cncr.30438
    http://bit.ly/2fULqFZ
  • Anne Korir, Emma Yu Wang, Peter Sasieni, Nathan Okerosi, Victor Ronoh and D. Maxwell Parkin. Cancer risks in Nairobi (2000–2014) by ethnic group. International journal of cáncer 2016, DOI: 10.1002/ijc.30502
    http://bit.ly/2gm5OAO
  • Comment. Massimo Cristofanilli. Metastatic breast cancer: focus on endocrine sensitivity. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)32418-7
    http://bit.ly/2fTL1bO
  • Roberto Rivera-Luna, Marta Zapata-Tarres, Jaime Shalkow-Klincovstein, Liliana Velasco-Hidalgo, Alberto Olaya-Vargas, Nicole Finkelstein-Mizrahi, Rocío Cárdenas-Cardós and Marco R. Aguilar-Ortiz. The burden of childhood cancer in Mexico: Implications for low- and middle-income countries. Pediatric Blood & Cancer 2016, DOI: 10.1002/pbc.26366
    http://bit.ly/2g5y5hx
  • Yu-Ning Wong, Nancy Roach, Neal J. Meropol. Addressing Patients’ Priorities as a Strategy to Improve Value. The Oncologist 2016; 21:1279-1282; doi:10.1634/theoncologist.2016-0184
    http://bit.ly/2gNDW9x

Noviembre

  • Henry Wabinga, Sujha Subramanian, Sarah Nambooze, Phoebe Mary Amulen, Patrick Edwards, Rachael Joseph, Martin Ogwang, Francis Okongo, D. Maxwell Parkin, Florence Tangka. Uganda experience—Using cost assessment of an established registry to project resources required to expand cancer registration. Cancer Epidemiology 2016, DOI: http://dx.doi.org/10.1016/j.canep.2016.11.004
    http://bit.ly/2fySE2m
  • P.A. van Luijt, E.A.M. Heijnsdijk and H.J. de Koning. Cost-effectiveness of the Norwegian breast cancer screening program. International Journal of Cancer 2016, DOI: 10.1002/ijc.30513
    http://bit.ly/2fzabr7
  • NEWS Talha Khan Burki. Palbociclib improves survival in advanced breast cancer. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30619-2
    http://bit.ly/2gsqOph
  • Amol K. Narang, Lauren Hersch Nicholas. Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer. JAMA Oncol. 2016. doi:10.1001/jamaoncol.2016.4865
    http://bit.ly/2gKfZ62
  • Zaid M. Abdelsattar, Samantha Hendren and Sandra L. Wong. The impact of health insurance on cancer care in disadvantaged communities. Cancer 2016, DOI: 10.1002/cncr.30431
    http://bit.ly/2faXWB2
  • Mariza Miranda Theme Filha, Maria do Carmo Leal, Elaine Fernandes Viellas de Oliveira, Ana Paula Esteves-Pereira and Silvana Granado Nogueira da Gama. Regional and social inequalities in the performance of Pap test and screening mammography and their correlation with lifestyle: Brazilian national health survey, 2013. International Journal for Equity in Health 2016 15:136
    http://bit.ly/2frTcIc
  • SEMINAR. Nadia Harbeck, Michael Gnant. Breast cáncer. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)31891-8
    http://bit.ly/2gqAl4a
  • Eva Johanna Kantelhardt, Kirstin Grosse Frie. How advanced is breast cancer in Africa?
    The Lancet Global Health 2016, DOI: http://dx.doi.org/10.1016/S2214-109X(16)30283-2
    http://bit.ly/2fs93X3
  • Elima Jedy-Agba, Valerie McCormack, Clement Adebamowo, Isabel dos-Santos-Silva. Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet Global Health 2016, DOI: http://dx.doi.org/10.1016/S2214-109X(16)30259-5
    http://bit.ly/2g8LlRb
  • Geraldine M. Leydon, Beth Stuart, Lisa Danquah, Katie Ekberg, Lucy Brindle, Sue Latter, Clare Moynihan, Peter Salmon, Sonia Howe, Elizabeth Stokoe and Paul Little. A descriptive survey of cancer helplines in the United Kingdom: Who they are, the services offered, and the accessibility of those services. Psycho-oncology 2016, DOI: 10.1002/pon.4293
    http://bit.ly/2feXcxV
  • Hae-Ra Han, Youngshin Song, Miyong Kim, Haley K. Hedlin, Kyounghae Kim, Hochang Ben Lee, Debra Roter. Breast and Cervical Cancer Screening Literacy Among Korean American Women: A Community Health Worker–Led Intervention. American Journal of Public Health doi: 10.2105/AJPH.2016.303522
    http://bit.ly/2fbokKK
  • Tina W. F. Yen, Liliana E. Pezzin, Jianing Li, Rodney Sparapani, Purushuttom W. Laud and Ann B. Nattinger. Effect of hospital volume on processes of breast cancer care: A National Cancer Data Base study. Cancer 2016 DOI: 10.1002/cncr.30413
    http://bit.ly/2fN5qwg
  • Felix Essiben, Pascal Foumane, Esther Ngo Um Meka, Patience Signing Soh, Julius Dohbit Sama, Eyongoben Osogo, Emile Telesphore Mboudou. Risk Factors for Breast Cancer: A Case-Control Study of 315 Women Followed in the Gynecology and Oncology Departments of Two University Teaching Hospitals in Yaounde, Cameroon. Journal of Obstetrics and Gynecology, 2016, DOI: 10.4236/ojog.2016.612085
    http://bit.ly/2fHVGTJ
  • Marit Valla, Lars Johan Vatten, Monica Jernberg Engstrøm, Olav Anton Haugen, Lars Andreas Akslen, Johan Håkon Bjørngaard, Anne Irene Hagen, Borgny Ytterhus, Anna Mary Bofin and Signe Opdahl. Molecular Subtypes of Breast Cancer: Long-term Incidence Trends and Prognostic Differences. Cancer Epidemiol Biomarkers Prev 2016,  DOI:10.1158/1055-9965.EPI-16-0427
    http://bit.ly/2fLMf4t
  • Ophira Ginsburg, Freddie Bray, Michel P Coleman, Verna Vanderpuye, Alexandru Eniu, S Rani Kotha, Malabika Sarker, Tran Thanh Huong, Claudia Allemani, Allison Dvaladze, Julie Gralow, Karen Yeates, Carolyn Taylor, Nandini Oomman, Suneeta Krishnan, Richard Sullivan, Dominista Kombe, Magaly M Blas, Groesbeck Parham, Natasha Kassami, Lesong Conteh. The global burden of women’s cancers: a grand challenge in global health. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)31392-7
    http://bit.ly/2fo84se
  • Lynette Denny, Silvia de Sanjose, Miriam Mutebi, Benjamin O Anderson, Jane Kim, Jose Jeronimo, Rolando Herrero, Karen Yeates, Ophira Ginsburg, Rengaswamy Sankaranarayanan. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)31795-0
    http://bit.ly/2fa5Pb0
  • Ophira Ginsburg, Rajan Badwe, Peter Boyle, Gemma Derricks, Anna Dare, Tim Evans, Alexandru Eniu, Jorge Jimenez, Tezer Kutluk, Gilberto Lopes, Sulma I Mohammed, You-Lin Qiao, Sabina Faiz Rashid, Diane Summers, Diana Sarfati, Marleen Temmerman, Edward L Trimble, Aasim I Padela, Ajay Aggarwal, Richard Sullivan. Changing global policy to deliver safe, equitable, and affordable care for women’s cancers. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)31393-9
    http://bit.ly/2fEaoxS
  • COMMENT. Otis W Brawley, Sally G Cowal. Civil society’s role in efforts to control women’s cancers. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)31799-8
    http://bit.ly/2f328Gy
  • COMMENT. Michelle Bachelet. Women, power, and the cancer divide. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)31800-1
    http://bit.ly/2fkZc6i
  • COMMENT. Udani Samarasekera, Richard Horton. Women’s cancers: shining a light on a neglected health inequity. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)31798-6
    http://bit.ly/2fkXOAz
  • Editorial. Cancer drug safety: time to re-focus on tackling adverse effects. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30519-8
    http://bit.ly/2eIjq8G
  • Guy Storme, S Dhaese, D Corens and Mark De Ridder. The cost of cancer care is not related to its outcomes. eCancer 2016, DOI: 10.3332/ecancer.2016.687
    http://bit.ly/2f0D4xV
  • Nadja Seidel, Friederike Stoelzel, Sandra Herrmann, Cornelia Zimmermann, Hendrik Berth, Melanie Glausch, Kristina Loewe, Michael Baumann, Gerhard Ehninger. Cancer: Education and Primary Prevention Starts in Childhood and Adolescence. Journal of Cancer Therapy, 2016, DOI: 10.4236/jct.2016.712084
    http://bit.ly/2f4GYYC
  • Junjie Xu, Wenwei Mao. Overview of Research and Development for Anticancer Drugs. Journal of Cancer Therapy, 2016, DOI: 10.4236/jct.2016.710077
    http://bit.ly/2eJQ9KL
  • Anthony J. Culyer. Ethics, priorities and cáncer. Journal of Cancer Policy 2016, DOI: http://dx.doi.org/10.1016/j.jcpo.2016.09.007
    http://bit.ly/2ep6zqY
  • Adrian Towse, Louis Garrison. Value assessment in precision cancer medicine. Journal of Cancer Policy 2016, DOI: http://dx.doi.org/10.1016/j.jcpo.2016.09.003
    http://bit.ly/2dHjl5b
  • Maria-João Cardoso, Fatima Cardoso. Overdoing in breast cancer: The risks of over-screening, over-diagnosing and over-treating the disease. The breast 2016, http://dx.doi.org/10.1016/j.breast.2016.10.010
    http://bit.ly/2fgbk8u
  • Andy Evans, Sarah Vinnicombe. Overdiagnosis in breast imaging. The breast 2016, http://dx.doi.org/10.1016/j.breast.2016.10.011
    http://bit.ly/2erNQi5
  • Karsten Juhl Jørgensen, Mette Kalager, Alexandra Barratt, Cornelia Baines, Per-Henrik Zahl, John Brodersen, Russell P. Harris. Overview of guidelines on breast screening: Why recommendations differ and what to do about it. The breast 2016 http://dx.doi.org/10.1016/j.breast.2016.08.002
    http://bit.ly/2fqfj2H
  • Yin Zhou, Gary A. Abel, Willie Hamilton, Kathy Pritchard-Jones, Cary P. Gross, Fiona M. Walter, Cristina Renzi, Sam Johnson, Sean McPhail, Lucy Elliss-Brookes & Georgios Lyratzopoulos. Diagnosis of cancer as an emergency: a critical review of current evidence. Nature Reviews Clinical Oncology (2016) doi:10.1038/nrclinonc.2016.155
    http://go.nature.com/2fqgbEy
  • John R. Scheel, Yamile Molina, Donald L. Patrick, Benjamin O. Anderson, Gertrude Nakigudde, Constance D. Lehman, Beti Thompson. Breast Cancer Downstaging Practices and Breast Health Messaging Preferences Among a Community Sample of Urban and Rural Ugandan Women. Journal of Global Oncology 2016,
    http://bit.ly/2ezGEjR
  • Sara E. Fischer, Olusegun I. Alatise, Akinwunmi O. Komolafe, Aba I. Katung, Adedeji A. Egberongbe, Samuel A. Olatoke, Olayide S. Agodirin, Oladapo A. Kolawole, Olaejerinde O. Olaofe, Omobolaji O. Ayandipo, Olorunda Rotimi, Murray F. Brennan, T. Peter Kingham. Establishing a Cancer Research Consortium in Low- and Middle-Income Countries: Challenges Faced and Lessons Learned. Healthcare Policy and Outcomes 2016, DOI: 10.1245/s10434-016-5624-2
    http://bit.ly/2ffCobI
  • Dickens, C., Pfeiffer, R.M., Anderson, W.F. et al. Investigation of breast cancer sub-populations in black and white women in South Africa. Breast Cancer Res Treat (2016). doi:10.1007/s10549-016-4019-1
    http://bit.ly/2foLZfB
  • News. India launches plan for national cancer screening programme. BMJ 2016;355:i5574
    http://bit.ly/2dVaDiB
  • Laura M. Spring, Megan R. Marshall and Erica T. Warner. Mammography decision making: Trends and predictors of provider communication in the Health Information National Trends Survey, 2011 to 2014. Cancer 2016, DOI: 10.1002/cncr.30378
    http://bit.ly/2fqFwAG
  • Sharon H. Giordano, Jiangong Niu, Mariana Chavez-MacGregor, Hui Zhao, Daria Zorzi, Ya-Chen Tina Shih, Benjamin D. Smith and Chan Shen. Estimating regimen-specific costs of chemotherapy for breast cancer: Observational cohort study. Cancer 2016, DOI: 10.1002/cncr.30274
    http://bit.ly/2dro8Hr
  • Florence K.L. Tangka, Sujha Subramanian, Patrick Edwards, Maggie Cole-Beebe, D. Maxwell Parkin, Freddie Bray, Rachael Joseph, Les Mery, Mona Saraiya, Cancer registration economic evaluation participants. Resource requirements for cancer registration in areas with limited resources: Analysis of cost data from four low- and middle-income countries. Cancer Epidemiology 2016, DOI: http://dx.doi.org/10.1016/j.canep.2016.10.009
    http://bit.ly/2f2WJfa
  • Esther de Vries, Constanza Pardo, Nelson Arias, Luis Eduardo Bravo, Edgar Navarro, Claudia Uribe, María Clara Yepez, Daniel Jurado, Luz Stella Garci, Marion Piñeros, Patrick Edwards, Maggie Cole Beebe, Florence Tangka, Sujha Subramanian. Estimating the cost of operating cancer registries: Experience in Colombia. Cancer Epidemiology 2016, DOI: http://dx.doi.org/10.1016/j.canep.2016.09.014
    http://bit.ly/2eYoDuz
  • Mona Saraiya, Florence K.L. Tangka, Samira Asma, Lisa C. Richardson. Importance of economic evaluation of cancer registration in the resource limited setting: Laying the groundwork for surveillance systems Cancer Epidemiology 2016, DOI: http://dx.doi.org/10.1016/j.canep.2016.10.001
    http://bit.ly/2eTjeqo
  • Shravani Koyande, Sujha Subramanian, Patrick Edwards, Sonja Hoover, Vinay Deshmane, Florence Tankga, Rajesh Dikshit, Mona Saraiya. Economic evaluation of Mumbai and its satellite cancer registries: Implications for expansion of data collection. Cancer Epidemiology 2016, DOI: http://dx.doi.org/10.1016/j.canep.2016.10.002
    http://bit.ly/2fhptpB
    Bijou R. Hunt, Marc S. Hurlbert. Black:white disparities in breast cancer mortality in the 50 largest cities in the United States, 2005–2014. DOI: http://dx.doi.org/10.1016/j.canep.2016.07.018
    http://bit.ly/2eYoFCG
  • Tuong L. Nguyen, Ye K. Aung, Christopher F. Evans, Gillian S. Dite, Jennifer Stone, Robert J. MacInnis, James G. Dowty, Adrian Bickerstaffe, Kelly Aujard, Johanna M. Rommens, Yun-Mi Song, Joohon Sung, Mark A. Jenkins, Melissa C. Southey, Graham G. Giles, Carmel Apicella, and John L. Hopper.  Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk. Int. J. Epidemiol. 2016, doi:10.1093/ije/dyw212
    http://bit.ly/2f39XZC
  • Tuvshinjargal Chimed, Tuvshingerel Sandagdorj, Ariana Znaor, Mathieu Laversanne, Badamsuren Tseveen, Purevsuren Genden and Freddie Bray. Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008–12. International Journal of Cancer 2016, DOI: 10.1002/ijc.30463
    http://bit.ly/2ePFlvj
  • NEWS. Talha Khan Burki. Incidence of breast cancer in women with type 2 diabetes. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30555-1
    http://bit.ly/2eTN91R
  • PERSONAL VIEW. Andrew Bottomley, Madeline Pe, Jeff Sloan, Ethan Basch, Franck Bonnetain, Melanie Calvert, Alicyn Campbell, Charles Cleeland, Kim Cocks, Laurence Collette, Amylou C Dueck, Nancy Devlin, Hans-Henning Flechtner, Carolyn Gotay, Eva Greimel, Ingolf Griebsch, Mogens Groenvold, Jean-Francois Hamel, Madeleine King, Paul G Kluetz, Michael Koller, et al. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30510-1
    http://bit.ly/2fr6ND1
  • E. Singh, M. Joffe, H. Cubasch, P. Ruff, S. A. Norris, P. T. Pisa. Breast cancer trends differ by ethnicity: a report from the South African National Cancer Registry (1994–2009). Eur J Public Health (2016) ckw191 DOI: http://dx.doi.org/10.1093/eurpub/ckw191
    http://bit.ly/2frf75C
  • Guy Storme, S Dhaese, D Corens and Mark De Ridder. The cost of cancer care is not related to its outcomes.  Ecancer 2016, DOI: 10.3332/ecancer.2016.687
    http://bit.ly/2f0D4xV

Octubre 2016

  • M. N. Kirshbaum, J. Dent, J. Stephenson, A. E. Topping, V. Allinson, M. McCoy and S. Brayford
    Open access follow-up care for early breast cancer: a randomised controlled quality of life analysis. Eur J Cancer Care 2016; 1–9  DOI: 10.1111/ecc.12577
    http://bit.ly/2cH3tmg
  • Lydia P. Buki, Micaela Reich and Emaan N. Lehardy.  “Our organs have a purpose”: body image acceptance in Latina breast cancer survivors. Psycho-Oncology 2016, DOI: 10.1002/pon.4270
    http://bit.ly/2cIUpxr
  • Jane Robertson, Ronald Barr, Lawrence N Shulman, Gilles B Forte & Nicola Magrini. Essential medicines for cancer: WHO recommendations and national priorities. Bull WHO 2016, http://dx.doi.org/10.2471/BLT.15.163998
    http://bit.ly/2cTCKkP
  • Caroline A. Thompson, Scarlett Lin Gomez, Katherine G. Hastings, Kristopher Kapphahn, Peter Yu, Salma Shariff-Marco, Ami S. Bhatt, Heather A. Wakelee, Manali I. Patel, Mark R. Cullen and Latha P. Palaniappan. The Burden of Cancer in Asian Americans: A Report of National Mortality Trends by Asian Ethnicity. Cancer Epidemiol Biomarkers Prev 2016 DOI:10.1158/1055-9965.EPI-16-0167
    http://bit.ly/2dzSmIS
  • Ellen G. Engelhardt, Arwen H. Pieterse, Paul K. J. Han, Nanny van Duijn-Bakker, Frans Cluitmans, Ed Maartense, Monique M. E. M. Bos, Nir I. Weijl, Cornelis J. A. Punt, Patricia Quarles van Ufford-Mannesse, Harm Sleeboom, Johanneke E. A. Portielje, Koos J. M. van der Hoeven, F. J. Sherida Woei-A-Jin, Judith R. Kroep, Hanneke C. J. M. de Haes, Ellen M. A. Smets, and Anne M. Stiggelbout Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer: Current Practices and Patients’ Perceptions of Uncertainty. Med Decis Making 2016 as doi:10.1177/0272989X16670639
    http://bit.ly/2dlK2gP

Septiembre 2016

  • Miranda M. Fidler, Isabelle Soerjomataram, Freddie Bray. A global view on cancer incidence and national levels of the human development index. IJC 2016, DOI: 10.1002/ijc.30382
    http://bit.ly/2cQZ4LJ
  • Fredholm, H., Magnusson, K., Lindström, L.S. et al. Long-term outcome in young women with breast cancer: a population-based study.  Breast Cancer Res Treat 2016, doi:10.1007/s10549-016-3983-9
    http://bit.ly/2d8PcPg
  • Enirtes Caetano Prates Melo, Evangelina Xavier Gouveia de Oliveira, Dóra Chor, Marilia Sá Carvalho and Rejane Sobrino Pinheiro. Inequalities in socioeconomic status and race and the odds of undergoing a mammogram in Brazil. International Journal for Equity in Health 2016 15:144
    http://bit.ly/2cFrJCj
  • Editorial. Launching a plan for the Cancer Moonshot. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)31643-9
    http://bit.ly/2cxDdMt
  • Editorial. Measuring the quality of cancer care in UK hospitals. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30393-X
    http://bit.ly/2bU3wbk
  • Adam M. Brufsky, Catherine Ormerod, Robyn Bell Dickson and Marc L. Citron. Understanding the Needs of Patients with Metastatic Breast Cancer: Results of the Make Your Dialogue Count Survey. The Breast Journal, 2016 DOI: 10.1111/tbj.12675
    http://bit.ly/2d90cMi
  • Uematsu, T. Possible supplemental breast cancer screening modalities. Breast Cancer, 2016 doi:10.1007/s12282-016-0727-y
    http://bit.ly/2c4vkLf
  • Michael J. Raphael, James J. Biagi, Weidong Kong, Mihaela Mates, Christopher M. Booth, William J. Mackillop.  The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 2016, doi:10.1007/s10549-016-3960-3
    http://bit.ly/2ccBBmS
  • Sarah J. O. Nomura, Chiranjeev Dash, Lynn Rosenberg, Julie Palmer, Lucile L. Adams-Campbell. Sedentary time and breast cancer incidence in African American women. Cancer Causes Control, 2016 doi:10.1007/s10552-016-0803-9
    http://bit.ly/2cdGefs
  • Nengliang Yao, Héctor E. Alcalá, Roger Anderson and Rajesh Balkrishnan. Cancer Disparities in Rural Appalachia: Incidence, Early Detection, and Survivorship. The Journal of Rural Health 2016, DOI: 10.1111/jrh.12213
    http://bit.ly/2cCBRex
  • L. M. Woods, M. Morris, and B. Rachet. No ‘cure’ within 12 years of diagnosis amongst breast cancer patients who are diagnosed via mammographic screening: women diagnosed in the West Midlands region of England 1989-2011. Ann Oncol first published 2016, doi:10.1093/annonc/mdw408
    http://bit.ly/2ca5YMK
  • Victoria Blakeman, Jack L. Williams, Qing-Jun Meng and Charles H. Streuli. Circadian clocks and breast cáncer. Breast Cancer Research 2016, DOI: 10.1186/s13058-016-0743-z
    http://bit.ly/2bKFHFB
  • Laura C. Pinheiro, Cleo A. Samuel, Katherine E. Reeder-Hayes, Stephanie B. Wheeler, Andrew F. Olshan, Bryce B. Reeve. Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors. Breast Cancer Res Treat 2016, doi:10.1007/s10549-016-3965-y
    http://bit.ly/2cybFpE
  • Editorial. Measuring the quality of cancer care in UK hospitals. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30393-X
    http://bit.ly/2bU3wbk
  • Comment. David Cameron. England's 30-day chemotherapy mortality: a measure of quality of care? The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30405-3
    http://bit.ly/2ciIkLl
  • Comment. Adam Brufsky. Is there room for bevacizumab in metastatic breast cancer? The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30295-9
    http://bit.ly/2c3n14u
  • Comment.  Melanie Morris, Manuela Quaresma, Janne Pitkäniemi, Eva Morris, Bernard Rachet, Michel P Coleman. Do cancer survival statistics for every hospital make sense? The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30391-6
    http://bit.ly/2bYwgyu
  • Michael Wallington, Emma B Saxon, Martine Bomb, Rebecca Smittenaar, Matthew Wickenden, Sean McPhail, Jem Rashbass, David Chao, John Dewar, Denis Talbot, Michael Peake, Timothy Perren, Charles Wilson, David Dodwell. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30383-7
    http://bit.ly/2c1XYwU
  • Jonathan Sicsic, Nicolas Krucien, Carine Franc. What are GPs' preferences for financial and non-financial incentives in cancer screening? Evidence for breast, cervical, and colorectal cancers. Social Science & Medicine 2016, http://dx.doi.org/10.1016/j.socscimed.2016.08.050
    http://bit.ly/2c3nVxM
  • Alberto d'Onofrio, Chiara Mazzetta, Chris Robertson, Michel Smans, Peter Boyle and Mathieu Boniol. Maps and atlases of cancer mortality: a review of a useful tool to trigger new questions. ecancer 10 670 / DOI: 10.3332/ecancer.2016.670
    http://bit.ly/2c3pr34

Agosto 2016

  • Tong Li, Claudia Mello-Thoms, Patrick C. Brennan. Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence. Breast Cancer Res Treat 2016, doi:10.1007/s10549-016-3947-0
    http://bit.ly/2bqUbW7
  • Faustine Williams, Stephen Jeanetta, Aimee S. James. Geographical Location and Stage of Breast Cancer Diagnosis: A Systematic Review of the Literature. Journal of Health Care for the Poor and Underserved 2016, DOI: 10.1353/hpu.2016.0102
    http://bit.ly/2bIc4VQ
  • COMMENT. Panagiota Economopoulou, George Pentheroudakis. Cancer of unknown primary: time to put the pieces of the puzzle together? The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30377-1
    http://bit.ly/2bWPfL6
  • Sebastian Moran, Anna Martínez-Cardús, Sergi Sayols, Eva Musulén, Carme Balañá, Anna Estival-Gonzalez, Cátia Moutinho, Holger Heyn, Angel Diaz-Lagares, Manuel Castro de Moura, Giulia M Stella, Paolo M Comoglio, Maria Ruiz-Miró, Xavier Matias-Guiu, Roberto Pazo-Cid, Antonio Antón, Rafael Lopez-Lopez, Gemma Soler, Federico Longo, Isabel Guerra, Sara Fernandez, Yassen Assenov, Christoph Plass, Rafael Morales, Joan Carles, David Bowtell, Linda Mileshkin, Daniela Sia, Richard Tothill, Josep Tabernero, Josep M Llovet, Manel Esteller Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30297-2
    http://bit.ly/2byIUVJ
  • Cardoso F, van't Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, DeLorenzi M, Glas AM, Golfinopoulos V, Goulioti T, Knox S, Matos E, Meulemans B, Neijenhuis PA, Nitz U, Passalacqua R, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Sotiriou C, Stork L, Straehle C, Thomas G, Thompson AM, van der Hoeven JM, Vuylsteke P, Bernards R, Tryfonidis K, Rutgers E, Piccart M; MINDACT Investigators. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. N Engl J Med. 2016;375(8):717-29,  doi: 10.1056/NEJMoa1602253.
    http://bit.ly/2bGZ8x0
  • Editorial. C.A. Hudis and M. Dickler. Increasing Precision in Adjuvant Therapy for Breast Cancer. N Engl J Med. 2016; 375:790-791, DOI: 10.1056/NEJMe1607947
    http://bit.ly/2bgFcEf
  • Kimberly A. Miller, Katherine Y. Wojcik, Cynthia N. Ramirez, Anamara Ritt-Olson, David R. Freyer, Ann S. Hamilton and Joel E. Milam. Supporting long-term follow-up of young adult survivors of childhood cancer: Correlates of healthcare self-efficacy. Pediatric Blood & Cancer 2016, DOI: 10.1002/pbc.26209
    http://bit.ly/2bPvM0H
  • Yan Guo, Shaneda Warren Andersen, Xiao-Ou Shu, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, Montserrat Garcia-Closas, Roger L. Milne, Marjanka K. Schmidt, Jenny Chang-Claude, Allison Dunning, Stig E. Bojesen, et al. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. PLoS Med 13(8): e1002105. doi:10.1371/journal.pmed.1002105
    http://bit.ly/2bMQ5ZQ
  • Elizabeth Meacham, Jackson Orem, Gertrude Nakigudde, Jo Anne Zujewski and Deepa Rao. Exploring stigma as a barrier to cancer service engagement with breast cancer survivors in Kampala, Uganda. Psycho-Oncology 2016, DOI: 10.1002/pon.4215
    http://bit.ly/2bZ4Qss
  • John Boyages, Ying Xu, Senia Kalfa, Louise Koelmeyer, Bonny Parkinson, Helen Mackie, Hector Viveros, Paul Gollan and Lucy Taksa. Financial cost of lymphedema borne by women with breast cáncer. Psycho-Oncology 2016, DOI: 10.1002/pon.4239
    http://bit.ly/2bIhZKl
  • Barsevick, A.M., Leader, A., Bradley, P.K. et al. Post-treatment problems of African American breast cancer survivors. Support Care Cancer 2016, doi:10.1007/s00520-016-3359-z
    http://bit.ly/2bsiCrf
  • Rena J. Pasick, Galen Joseph, Susan Stewart, Celia Kaplan, Robin Lee, Judith Luce, Sharon Davis, Titas Marquez, Tung Nguyen, Claudia Guerra. Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial. American Journal of Public Health 2016, doi: 10.2105/AJPH.2016.303312
    http://bit.ly/2btqZxu
  • Short Communication. Badria AlJohani, Osama AlMalik, Ehab Anwar, Asma Tulbah, Mohamed Alshabanah, Adher AlSyaed, Dahish Ajarim and Taher ALTweigeri. Impact of Surgery on Survival in Stage IV Breast Cancer. The Breast Journal 2016, 2016 DOI: 10.1111/tbj.12662
    http://bit.ly/2bWQREH
  • Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, van den Broek JJ, Alagoz O, Sprague BL, van Ravesteyn NT, Near AM, Gangnon RE, Hampton JM, Chandler Y, de Koning HJ, Mandelblatt JS, Tosteson AN; Breast Cancer Surveillance Consortium and Cancer Intervention and Surveillance Modeling Network. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. Ann Intern Med. 2016 Aug 23. doi: 10.7326/M16-0476
    http://bit.ly/2bJDA1z
  • Editorial. Berg CD. Breast Cancer Screening Interval: Risk Level May Matter. Ann Intern Med. 2016 Aug 23. doi: 10.7326/M16-1791.
    http://bit.ly/2bIUfSc
  • Carlos Gil Ferreira, Maria Isabel Achatz, Patricia Ashton-Prolla, Maria Dirlei Begnami, Fabricio K Marchini, Stephen Doral Stefani. Brazilian health-care policy for targeted oncology therapies and companion diagnostic testing. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30171-1
    http://bit.ly/2b8kh35
  • Comment. Corey Casper, Christina Fitzmaurice. Infection-related cancers: prioritising an important and eliminable contributor to the global cancer burden. The Lancet Global Health 2016, DOI: http://dx.doi.org/10.1016/S2214-109X(16)30169-3
    http://bit.ly/2aF3ruC
  • Martyn Plummer, Catherine de Martel, Jerome Vignat, Jacques Ferlay, Freddie Bray, Silvia Franceschi. Global burden of cancers attributable to infections in 2012: a synthetic analysis. The Lancet Global Health 2016, DOI: http://dx.doi.org/10.1016/S2214-109X(16)30143-7
    http://bit.ly/2aagVJu
  • Lucy Grant, Amrit Sangha, Sara Lister, Theresa Wiseman. Cancer and the family: assessment, communication and brief interventions—the development of an educational programme for healthcare professionals when a parent has cáncer. BMJ Support Palliat Care 2016, doi:10.1136/bmjspcare-2015-001006
    http://bit.ly/2b8tAjv
  • Rhiana S. Menen and Kelly K. Hunt. Considerations for the Treatment of Young Patients with Breast Cancer.  The Breast Journal 2016, DOI: 10.1111/tbj.12644
    http://bit.ly/2b8xVTZ
  • Sivan Agranat, Hagit Baris, Inbal Kedar, Mordechai Shochat, Shulamith Rizel, Shlomit Perry, David Margel, Aaron Sulkes and Rinat Yerushalmi. Earlier Age of Breast Cancer Onset in Israeli BRCA Carriers—Is it a Real Phenomenon? The Breast Journal 2016, DOI: 10.1111/tbj.12653
    http://bit.ly/2bFCvc0
  • Jad Chahoud, Adele Semaan, and Alyssa Rieber. Wealth, Health Expenditure, and Cancer: A National Perspective. J Natl Compr Canc Netw 2016;14:972-978
    http://bit.ly/2blMBiY
  • Deandrea S, Molina-Barceló A, Uluturk A, Moreno J, Neamtiu L, Peiró-Pérez R, Saz-Parkinson Z, Lopez-Alcalde J, Lerda D, Salas D. Presence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results from an international survey. Prev Med. 2016 doi: 10.1016/j.ypmed.2016.08.021.
    http://bit.ly/2bTpbUL
  • Lynn Chollet-Hinton, Carey K. Anders, Chiu-Kit Tse, Mary Beth Bell, Yang Claire Yang, Lisa A. Carey, Andrew F. Olshan and Melissa A. Troester. Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study. Breast Cancer Research 2016, DOI: 10.1186/s13058-016-0736-y
    http://bit.ly/2b03gL4
  • Deependra Singh, Janne Pitkäniemi, Nea Malila, Ahti Anttila. Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study. Cancer Res Treat 2016, doi:10.1007/s10549-016-3931-8
    http://bit.ly/2aAxVKS
  • A. M. F. Verschoor, A. Kuijer, J. Verloop, C. H. Van Gils, G. S. Sonke, A. Jager, T. van Dalen, S. G. Elias. Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level. Breast Cancer Research and Treatment 2016, doi:10.1007/s10549-016-3940-7
    http://bit.ly/2aRljjQ
  • Editorial. Michael T. Halpern and Otis W. Brawley. Insurance status, health equity, and the cancer care continuum. Cancer 2016,  DOI: 10.1002/cncr.30158
    http://bit.ly/2aPGekg
  • Hoda Anton-Culver, Jenny Chang, Freddie Bray, Ariana Znaor, Lisa Stevens, Sultan Eser, Barbara Silverman, Omar Nimri, Pavlos Pavlou, Haris Charalambous, Anna Demetriou, Kevin Ward, Argyrios Ziogas. Cancer burden in four countries of the Middle East Cancer Consortium (Cyprus; Jordan; Israel; Izmir (Turkey)) with comparison to the United States surveillance; epidemiology and end results program. Cancer epidemiology 2016, DOI: http://dx.doi.org/10.1016/j.canep.2016.06.004
    http://bit.ly/2b1Woe3
  • Comment. Graham A Colditz, Karen M Emmons. The role of universal health coverage in reducing cancer deaths and disparities. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)30376-2
    http://bit.ly/2bfH8rK
  • Mahiben Maruthappu, Johnathan Watkins, Aisyah Mohd Noor, Callum Williams, Raghib Ali, Richard Sullivan, Thomas Zeltner, Rifat Atun. Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysis. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)00577-8
    http://bit.ly/20R6LSi
  • K. Handayani, M. N. Sitaresmi, E. Supriyadi, P. H. Widjajanto, D. Susilawati, F. Njuguna, P. M. van de Ven, G. J. L. Kaspers and S. Mostert. Delays in diagnosis and treatment of childhood cancer in Indonesia. Pediatric Blood & Cancer 2016,  DOI: 10.1002/pbc.26174
    http://bit.ly/2bspOUU

 

Julio 2016

  • Michael E Jones, Minouk J Schoemaker, Lauren Wright, Emily McFadden, James Griffin, Dawn Thomas, Jane Hemming, Karen Wright, Alan Ashworth and Anthony J Swerdlow. Menopausal hormone therapy and breast cancer: what is the true size of the increased risk? Br J Cancer 2016; doi:10.1038/bjc.2016.231
    http://go.nature.com/2ac3t8j
  • News. Nigel Hawkes. New Cancer Drugs Fund is flawed without NICE reform, says Roche. BMJ 2016;354:i4216
    http://bit.ly/2aExWB7
  • Kathryn J. Ruddy, Hao Guo, Emily L. Baker, Matthew J. Goldstein, Erin E. Mullaney, Lawrence N. Shulman and Ann H. Partridge. Randomized phase 2 trial of a coordinated breast cancer follow-up care program. Cancer 2016, DOI: 10.1002/cncr.30206
    http://bit.ly/2aCOcRw
  • David C. Whiteman, Louise F. Wilson. The fractions of cancer attributable to modifiable factors: A global review. Cancer Epidemiology 2016,
    http://bit.ly/2aEzsDu
  • Martyn Plummer, Catherine de Martel, Jerome Vignat, Jacques Ferlay, Freddie Bray, Silvia Franceschi. Global burden of cancers attributable to infections in 2012: a synthetic analysis. The Lancet Global Health 2016; DOI: http://dx.doi.org/10.1016/S2214-109X(16)30143-7
    http://bit.ly/2aagVJu
  • Comment. Corey Casper, Christina Fitzmaurice. Infection-related cancers: prioritising an important and eliminable contributor to the global cancer burden.  The Lancet Global Health 2016; DOI: http://dx.doi.org/10.1016/S2214-109X(16)30169-3
    http://bit.ly/2aF3ruC
  • NEWS. Susan Mayor. Differences in availability of cancer drugs across Europe. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30378-3
    http://bit.ly/2akAdlo
  • S.G. Smith, L.M. McGregor, R. Raine, J. Wardle, C. von Wagner and K.A. Robb. Inequalities in cancer screening participation: examining differences in perceived benefits and barriers. Psycho‐Oncology 2016  DOI: 10.1002/pon.4195
    http://bit.ly/29CPSYc
  • Megan S. Rice, A. Heather Eliassen, Susan E. Hankinson, Elizabeth B. Lenart, Walter C. Willett, Rulla M. Tamimi. Breast Cancer Research in the Nurses’ Health Studies: Exposures Across the Life Course. American Journal of Public Health. 2016, doi: 10.2105/AJPH.2016.303325
    http://bit.ly/2apSiJD
  • Jennifer Gass, Beth Dupree, Sandhya Pruthi, Diane Radford, Irene Wapnir, Reza Antoszewska ANP-C, Audrey Curtis, Nathalie Johnson. Breast Cancer Survivorship: Why, What and When? Annals of Surgical Oncology 2016; DOI 10.1245/s10434-016-5403-0
    http://bit.ly/29TO8Jk
  • Johnson Kathleen J.,  Minchew, Leigh A., Richter Sara, Craft Cheryl, Lerner Rachel. Providing Breast Cancer Survivorship: Lessons Learned From a Pilot Project Implementation. Cancer Nursing 2016, doi: 10.1097/NCC.0000000000000414
    http://bit.ly/29UzVvD
  • Samilia Obeng-Gyasi, Lisa Tolnitch, Rachel A. Greenup, E. Shelley Hwang. The Impact of the Affordable Care Act on North Carolinian Breast Cancer Patients Seeking Financial Support for Treatment. Annals of Surgical Oncology 2016, DOI 10.1245/s10434-016-5311-3
    http://bit.ly/29VQXfh
  • Plichta JK, Rai U, Tang R, Coopey SB, Buckley JM, Gadd MA, Specht MC, Hughes KS, Taghian AG, Smith BL. Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger. Ann Surg Oncol. 2016
    http://bit.ly/29WA32U
  • Minouk J. Schoemaker, Michael E. Jones, Lauren B. Wright, James Griffin, Emily McFadden, Alan Ashworth and Anthony J. Swerdlow. Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom. Breast Cancer Research 2016, DOI: 10.1186/s13058-016-0733-1
    http://bit.ly/29OIfjO
  • Mona P. Tan. Mastectomy versus breast conservation treatment: is there a true survival difference? Breast Cancer Research and Treatment 2016, DOI 10.1007/s10549-016-3903-z
    http://bit.ly/2agfhHK
  • Frank Naku Ghartey Jnr, Akwasi Anyanful, Sebastian Eliason, Saanid Mohammed Adamu, and Samuel Debrah. Pattern of breast cancer distribution in Ghana – a survey to enhance early detection, diagnosis and treatment.
    http://bit.ly/2a4CRe3
  • Custers JA, Gielissen MF, de Wilt JH, Honkoop A, Smilde TJ, van Spronsen DJ, van der Veld W, van der Graaf WT, Prins JB. Towards an evidence-based model of fear of cancer recurrence for breast cancer survivors. J Cancer Surviv. 2016,
    http://bit.ly/29CIxI7
  • Sauvaget C, Nishino Y, Konno R, Tase T, Morimoto T, Hisamichi S. Challenges in breast and cervical cancer control in Japan. Lancet Oncol. 2016 doi: 10.1016/S1470-2045(16)30121-8.
    http://bit.ly/29JZdNw
  • Ghislain I, Zikos E, Coens C, Quinten C, Balta V, Tryfonidis K, Piccart M, Zardavas D, Nagele E, Bjelic-Radisic V, Cardoso F, Sprangers MA, Velikova G, Bottomley A; European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group; Breast Cancer Group; EORTC Headquarters. Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials. Lancet Oncol. 2016 doi: 10.1016/S1470-2045(16)30099-7.
    http://bit.ly/29oa55m
  • NEWS. Holly Baker. Adaptive treatments show promise in breast cáncer. Lancet Oncol. 2016 DOI: http://dx.doi.org/10.1016/S1470-2045(16)30315-1
    http://bit.ly/2agWnQW
  • S.G. Smith, L.M. McGregor, R. Raine, J. Wardle, C. von Wagner and K.A. Robb. Inequalities in cancer screening participation: examining differences in perceived benefits and barriers. Psycho-Oncology  2016, DOI: 10.1002/pon.4195
    http://bit.ly/29CPSYc
  • Daniel A. Goldstein, Michal Sarfaty. Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World. The Oncologist 2016; doi:10.1634/theoncologist.2016-0106
    http://bit.ly/29ITkiA
  • Gustavo Nigenda, Maria Cecilia Gonzalez-RobledoEmail author, Luz Maria Gonzalez-Robledo and Rosa Maria Bejarano-Arias. Breast cancer policy in Latin America: account of achievements and challenges in five countries. Globalization and Health 2016, DOI: 10.1186/s12992-016-0177-5
    http://bit.ly/29O1bjv
  • Brittany L. Bychkovsky, Nancy U. Lin. Imaging in the evaluation and follow-up of early and advanced breast cancer: When, why, and how often? The Breast 2016, doi:10.1016/j.breast.2016.06.017
    http://bit.ly/2ah73ix
  • Comment. Philippe Autier. Age at cancer diagnosis and interpretation of survival statistics. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30048-1
    showArticle Info
    http://bit.ly/1Z62gmm 
  • Comment. Rejin Kebudi, Ibrahim Bayram, Begul Yagci-Kupeli, Serhan Kupeli, Gulay Sezgin, Esra Pekpak, Yesim Oymak, Dilek Ince, Suna Emir, Deniz Tugcu, Gulcihan Ozek, Ali Bay, Funda Tayfun Kupesiz, Sema Vural, Suheyla Ocak, Yontem Yaman, Yavuz Koksal, Cetin Timur, Selma Unal, Canan Vergin. Refugee children with cancer in Turkey. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30211-X
    http://bit.ly/29cS65b
  • NEWS. Dinesh C Sharma. Cancer data in India show new patterns. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30202-9
    http://bit.ly/1TODZB
  • Annalisa Trama, Laura Botta, Roberto Foschi, Andrea Ferrari, Charles Stiller, Emmanuel Desandes, Milena Maria Maule, Franco Merletti, Gemma Gatta, EUROCARE-5 Working Group. Survival of European adolescents and young adults diagnosed with cancer in 2000–07: population-based data from EUROCARE-5. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)00162-5
    http://bit.ly/1WZp7m8
  • Irina Ghislain, Efstathios Zikos, Corneel Coens, Chantal Quinten, Vasiliki Balta, Konstantinos Tryfonidis, Martine Piccart, Dimitrios Zardavas, Eva Nagele, Vesna Bjelic-Radisic, Fatima Cardoso, Mirjam A G Sprangers, Galina Velikova, Andrew Bottomley, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group, Breast Cancer Group, EORTC Headquarters. Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30099-7
    http://bit.ly/29oa55m
  • Kathryn Bouskill , Michael Kramer. The impact of cancer and quality of life among long-term survivors of breast cancer in Austria. Supportive Care in Cancer 2016, DOI 10.1007/s00520-016-3319-7
    http://bit.ly/29AYZc2
  • Christine Paul , Allison Boyes, Alix Hall, Alessandra Bisquera, Annie Miller, Lorna O’Brien. The impact of cancer diagnosis and treatment on employment, income, treatment decisions and financial assistance and their relationship to socioeconomic and disease factors. Supportive Care in Cancer 2016, DOI 10.1007/s00520-016-3323-y
    http://bit.ly/29lJI2T

Junio, 2016

  • Stephanie E. Leung, Ilanit Ben-Nachum, Anat Kornecki. New Palpable Breast Lump With Recent Negative Mammogram: Is Repeat Mammography Necessary? American Journal of Roentgenology. 2016;207:200-204. 10.2214/AJR.15.14799
    http://bit.ly/28Y09Ss
  • Hieken TJ, Mutter RM, Jakub JW, Boughey JC, Degnim AC, Sukov WR, Childs S, Corbin KS, Furutani KM, Whitaker TJ, Park SS. A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer. Ann Surg Oncol. 2016
    http://bit.ly/28Sve6C
  • Arnold M, Rentería E, Conway DI, Bray F, Van Ourti T, Soerjomataram I. Inequalities in cancer incidence and mortality across medium to highly developed countries in the twenty-first century. Cancer Causes Control. 2016,
    http://bit.ly/28YZ8d3
  • Daniela Bernardi, Petra Macaskill, Marco Pellegrini, Marvi Valentini, Carmine Fantò, Livio Ostillio, Paolina Tuttobene, Andrea Luparia, Nehmat Houssami. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30101-2
    http://bit.ly/28TgJNQ
  • Comment. Beryl McCormick. The mastectomy myth. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30219-4
    http://bit.ly/28UaRbW
  • Marissa C van Maaren, Linda de Munck, Geertruida H de Bock, Jan J Jobsen, Thijs van Dalen, Sabine C Linn, Philip Poortmans, Luc J A Strobbe, Sabine Siesling. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30067-5
    http://bit.ly/28YkchL
  • Comment. Ophira Ginsburg. Global disparities in HPV vaccination. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S2214-109X(16)30107-3
    http://bit.ly/28UV3BF
  • Nazzal Z, Sholi H, Sholi S, Sholi M, Lahaseh R. Mammography Screening Uptake among Female Health Care Workers in Primary Health Care Centers in Palestine - Motivators and Barriers. Asian Pac J Cancer Prev. 2016;17(5):2549-54.
    http://bit.ly/1W4r27I
  • A. Sollie, C.W. Helsper, R.J.M. Ader, M.G.E.M. Ausems, J.C. van der Wouden and M.E. Numans. Primary care management of women with breast cancer-related concerns—a dynamic cohort study using a network database. European Journal of Cancer Care 2016, DOI: 10.1111/ecc.12526
    http://bit.ly/1tC8KzH
  • N. García-Rueda, A. Carvajal Valcárcel, M. Saracíbar-Razquin and M. Arantzamendi Solabarrieta. The experience of living with advanced-stage cancer: a thematic synthesis of the literature. European Journal of Cancer Care 2016, DOI: 10.1111/ecc.12523
    http://bit.ly/1UUI1qq
  • Susanne Singer, Julia Roick, Susanne Briest, Sylvia Stark, Ines Gockel, Andreas Boehm, Kirsten Papsdorf, Jürgen Meixensberger, Tobias Müller, Torsten Prietzel, Franziska Schiefke, Anja Dietel, Jens Bräunlich and Helge Danker. Impact of socio-economic position on cancer stage at presentation: Findings from a large hospital-based study in Germany. International Journal of Cancer 2016, DOI: 10.1002/ijc.30212
    http://bit.ly/28JMnQt
  • Short Communication. Steven Lehrer, Sheryl Green and Kenneth E. Rosenzweig.  Affluence and Breast Cancer.  The Breast Journal 2016, DOI: 10.1111/tbj.12630
    http://bit.ly/28NDCDy
  • Richard Sposto, Theresa H.M. Keegan, Cheryl Vigen, Marilyn L. Kwan, Leslie Bernstein, Esther M. John, Iona Cheng, Juan Yang, Jocelyn Koo, Allison W. Kurian, Bette J. Caan, Yani Lu, Kristine R. Monroe, Salma Shariff-Marco, Scarlett Lin Gomez, and Anna H. Wu. The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality. Cancer Epidemiol Biomarkers Prev 2016; doi:10.1158/1055-9965.EPI-15-1326
    http://bit.ly/28MNYoj
  • Smita Bhatia, Todd M. Gibson, Kirsten K. Ness, Qi Liu, Kevin C. Oeffinger, Kevin R. Krull, Paul C. Nathan, Joseph P. Neglia, Wendy Leisenring, Yutaka Yasui, Leslie L. Robison and Gregory T. Armstrong. Childhood cancer survivorship research in minority populations: A position paper from the Childhood cancer Survivor Study. Cancer 2016, DOI: 10.1002/cncr.30072
    http://bit.ly/1UjMf8r
  • Delgermaa Demchig, Patrick Brennan, and Claudia Mello-Thoms. Breast cancer in Mongolia: An increasingly important health policy issue. International Journal of Breast Cancer 2016; in press
    http://bit.ly/1r72dLk
  • Allison Silverstein, Rachita Sood, and Ainhoa Costas-Chavarri. Breast cancer in Africa: limitations and opportunities for application of genomic medicine.  International Journal of Breast Cancer 2016; in press
    http://bit.ly/25DJM0k
  • Elizabeth T. Loggers, Diana Buist, Laura S. Gold, Steve Zeliadt, Rachel Hunter-Merrill, R. Etzioni, Scott D. Ramsey, Sean Sullivan, and Larry G. Kessler. Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer. International Journal of Breast Cancer 2016; in press
    http://bit.ly/1UBwQTy
  • Ying Liu, Shaneda Warren Andersen, Wanqing Wen, Yu-Tang Gao, Qing Lan, Nathaniel Rothman, Bu-Tian Ji, Gong Yang, Yong-Bing Xiang, Xiao-Ou Shu and Wei Zheng. Prospective cohort study of general and central obesity, weight change trajectory and risk of major cancers among Chinese women. International Journal of Cancer 2016; DOI: 10.1002/ijc.30187
    http://bit.ly/1sW9Sxe
  • Sashidhar Manthravadi, Anuj Shrestha and Sheshadri Madhusudhana. Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis. International Journal of Cancer 2016; DOI: 10.1002/ijc.30185
    http://bit.ly/1RTMRj6
  • Comment. Foluso Ishola, Oluwatosin Omole. A vision for improved cancer screening in Nigeria. The Lancet Global Health 2016, DOI: http://dx.doi.org/10.1016/S2214-109X(16)30062-6
    http://bit.ly/1O8yEnP
  • Editorial. When is a carcinogen not a carcinogen? The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30138-3
    http://bit.ly/1WAdD88
  • Comment. Oscar Gonzalez-Ramella, Daniel Freigeiro, Mauricio E Castellanos, Alejandro M Arancibia, Carlos Rodriguez-Galindo, Monika L Metzger. Joining forces for children with cancer in Latin America. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30133-4
    http://bit.ly/1O8zbpU
  • Shiva Raj Mishra, Vishnu Khanal, Per Kallestrup. Cancer in the aftermath of Nepal's earthquakes. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)00164-9
    http://bit.ly/1O8Azso
  • News. Talha Khan Burki. Charities raise alarm over changes to UK Cancer Drugs Fund. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30162-0
    http://bit.ly/25DWrQV
  • Reportage. Georgina Kenyon. Cancer care in Bali. The Lancet Oncology 2016,
    http://bit.ly/1VDM50A
  • Laura E. Simonelli, Scott D. Siegel and Nicole M. Duffy. Fear of cancer recurrence: a theoretical review and its relevance for clinical presentation and management. Psycho-Oncology 2016, DOI: 10.1002/pon.4168
    http://bit.ly/1WAgBJX
  • Editorial. Eduardo Cazap, Benjamin O. Anderson. Vision for the Global Health and Cancer Section. The Oncologist 2016 vol. 21 no. 5 521-522
    http://bit.ly/24p8Ky7

Mayo, 2016

  • Adam Hinzey, Monica M. Gaudier-Diaz, Maryam B. Lustberg and A. Courtney DeVries. Breast cancer and social environment: getting by with a little help from our friends. Breast Cancer Research 2016 18:54
    http://bit.ly/1RwVhwM
  • Laurel A. Habel, Jafi A. Lipson, Ninah Achacoso, Joseph H. Rothstein, Martin J. Yaffe, Rhea Y. Liang, Luana Acton, Valerie McGuire, Alice S. Whittemore, Daniel L. Rubin and Weiva Sieh. Case-control study of mammographic density and breast cancer risk using processed digital mammograms.  Breast Cancer Research201618:53
    http://bit.ly/1TNck3A
  • Comment. Thomas C. Randall, AnneKathryn Goodman, Kathleen Schmeler, John Durfee, Rene Pareja, Adnan Munkarah, Stephen Rulisa, Rahel Ghebre, Edward L. Trimble, Linus Chuang. Cancer and the world's poor: What's a gynecologic cancer specialist to do? Gynecologic Oncology 2016, doi: , http://dx.doi.org/10.1016/j.ygyno.2016.05.018
    http://bit.ly/1TIO0S4
  • Comment. Graham A Colditz, Karen M Emmons. The role of universal health coverage in reducing cancer deaths and disparities. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)30376-2
    http://bit.ly/1Z2z9jO
  • Mahiben Maruthappu, Johnathan Watkins, Aisyah Mohd Noor, Callum Williams, Raghib Ali, Richard Sullivan, Thomas Zeltner, Rifat Atun. Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysis. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(16)00577-8
    http://bit.ly/1sAeFEr
  • NEWS Dinesh C Sharma. Cancer data in India show new patterns. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30202-9
    http://bit.ly/1TODZB8
  • COMMENT Philippe Autier. Age at cancer diagnosis and interpretation of survival statistics. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)30048-1
    http://bit.ly/1Z62gmm
  • Annalisa Trama, Laura Botta, Roberto Foschi, Andrea Ferrari, Charles Stiller, Emmanuel Desandes, Milena Maria Maule, Franco Merletti, Gemma Gatta, EUROCARE-5 Working Group. Survival of European adolescents and young adults diagnosed with cancer in 2000–07: population-based data from EUROCARE-5. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)00162-5
    http://bit.ly/1WZp7m8
  • Adebola A. Adedimeji, David Lounsbury, Oluwafemi Popoola, Chioma Asuzu, Akinmayowa Lawal, V. Oladoyin, Cassandra Crifase, Ilir Agalliu, Viswanathan Shankar and Akindele Adebiyi. Improving outcomes in cancer diagnosis, prevention and control: barriers, facilitators and the need for health literacy in Ibadan Nigeria. Psycho-Oncology 2016, DOI: 10.1002/pon.4158
    http://bit.ly/1UbCI2L
  • Adam Lundqvist, Emelie Andersson, Ida Ahlberg, Mef Nilbert, Ulf Gerdtham. Socioeconomic inequalities in breast cancer incidence and mortality in Europe—a systematic review and meta-analysis. Eur J Public Health 2016, DOI: http://dx.doi.org/10.1093/eurpub/ckw070
    http://bit.ly/1WRH71g
  • Bernardo H.L. Goulart. Value: The Next Frontier in Cancer Care. The Oncologist 2016; doi:10.1634/theoncologist.2016-0174
    http://bit.ly/1P6hwzk
  • Jessica A. Hill, Kahaki Kimani, Abby White, Faith Barasa, Morgan Livingstone, Brenda L. Gallie and Helen Dimaras. Achieving optimal cancer outcomes in East Africa through multidisciplinary partnership: a case study of the Kenyan National Retinoblastoma Strategy group. Globalization and Health 2016, DOI: 10.1186/s12992-016-0160-1
    http://bit.ly/25s7L5X
  • Maas P, Barrdahl M, Joshi AD, Auer PL, Gaudet MM, Milne RL, Schumacher FR, Anderson WF, et al Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. JAMA Oncol. 2016 doi: 10.1001/jamaoncol.2016.1025..
    http://bit.ly/1VkDPT5
  • Editorial. William D. Dupont, Jeffrey D. Blume, Jeffrey R. Smith. Building and Validating Complex Models of Breast Cancer Risk. JAMA Oncol. 2016,   doi:10.1001/jamaoncol.2016.0878
    http://bit.ly/1Z65CFZ
  • Alexandra Bukowski- The Potential Role of Patient Navigation in Low- and Middle-Income Countries for Patients With Cancer. JAMA Oncol. 2016,  doi:10.1001/jamaoncol.2016.0766
    http://bit.ly/1RzMxGi
  • Per Skaane. Breast cancer screening with digital breast tomosynthesis. Breast Cancer 2016, DOI 10.1007/s12282-016-0699-y
    http://bit.ly/1XERncL
  • Hellen Gelband, Rengaswamy Sankaranarayanan, Cindy L Gauvreau, Susan Horton, Benjamin O Anderson, Freddie Bray, James Cleary, Anna J Dare, Lynette Denny, Mary K Gospodarowicz, Sumit Gupta, Scott C Howard, David A Jaffray, Felicia Knaul, Carol Levin, Linda Rabeneck, Preetha Rajaraman, Terrence Sullivan, Edward L Trimble, Prabhat Jha, Disease Control Priorities-3 Cancer Author Group. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(15)00755-2
    http://bit.ly/1NSL9lc
  • PERSPECTIVE D.R. Lowy and F.S. Collins. Aiming High — Changing the Trajectory for Cancer. N Engl J Med 2016; 374:1901-1904
    http://bit.ly/1S3efvm
  • Neha Vapiwala. Replacing Urban Myths About Cancer With Community Wisdom: Putting a Finger on Cancer Disparities. JAMA Oncol 2016, doi:10.1001/jamaoncol.2015.6566
    http://bit.ly/1Tt1wWT
  • Graham A. Colditz, Siobhan Sutcliffe. The Preventability of Cancer: Stacking the Deck. JAMA Oncol 2016, doi:10.1001/jamaoncol.2016.0889  
    http://bit.ly/1OBHxRy
  • Supriya G. Mohile, Arti Hurria, Harvey J. Cohen, Julia H. Rowland, Corinne R. Leach, Neeraj K. Arora, Beverly Canin, Hyman B. Muss, Allison Magnuson, Marie Flannery, Lisa Lowenstein, Heather G. Allore, Karen M. Mustian, Wendy Demark-Wahnefried, Martine Extermann, Betty Ferrell, Sharon K. Inouye, Stephanie A. Studenski and William Dale. Improving the quality of survivorship for older adults with cancer. Cancer 2016; DOI: 10.1002/cncr.30053
    http://bit.ly/1rKSj34
  • Miyako Takahashi. Cancer survivorship: current status of research, care, and policy in Japan. Jpn. J. Clin. Oncol. 2016 doi:10.1093/jjco/hyw057
    http://bit.ly/24RBBNy
  • Ana-Maria Forsea. Cancer registries in Europe—going forward is the only option. ecancer 2016, 10:641 DOI: 10.3332/ecancer.2016.64z
    http://bit.ly/1R1U7sJ
  • Christopher J Portier, Bruce K Armstrong, Bruce C Baguley, Xaver Baur, Igor Belyaev, Robert Bellé, Fiorella Belpoggi, Annibale Biggeri, Maarten C Bosland, Paolo Bruzzi, Lygia Therese Budnik, Merete D Bugge, Kathleen Burns, Gloria M Calaf, David O Carpenter, Hillary M Carpenter, Lizbeth López-Carrillo, et al. Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA). J Epidemiol Community Health 2016 doi:10.1136/jech-2015-207005
    http://bit.ly/1q5AABG
  • Correspondence. Marcelle Bernstein. Intraoperative radiation therapy for breast cancer: a patient's view. The Lancet 2016; DOI: http://dx.doi.org/10.1016/S0140-6736(16)30415-9
    http://bit.ly/24AKr5G
  • Editorial. Improved drug access in low and middle-income countries. The Lancet Oncology 2016; DOI: http://dx.doi.org/10.1016/S1470-2045(16)30068-7
    http://bit.ly/1SByCEG
  • Christiane Bleich, Cathrin Büscher, Hanne Melchior, Anna Grochocka, Andrea Thorenz, Holger Schulz, Uwe Koch and Birgit Watzke. Effectiveness of case management as a cross-sectoral healthcare provision for women with breast cancer. Psycho-Oncology 2016; DOI: 10.1002/pon.4139
    http://bit.ly/1O667z0
  • DePinho, Ronald A; Hawk, Ernest. Cancer prevention in developing countries: a vision for preserving health in Mexico.  Salud pública Méx vol.58 no.2 Cuernavaca mar./abr. 2016
     http://bit.ly/1TuR2TB
  • Lazcano-Ponce, Eduardo; Mohar-Betancourt, Alejandro; Meneses-García, Abelardo; Hernández-Ávila, Mauricio. Cancer burden in Mexico: urgent challenges to be met. Salud pública Méx vol.58 no.2 Cuernavaca mar./abr. 2016
    http://bit.ly/1SWBTuW
  • BRAY, Freddie y  PINEROS, Marion. Cancer patterns, trends and projections in Latin America and the Caribbean: a global context. Salud pública Méx 2016, vol.58, n.2, pp.104-117. ISSN 0036-3634.
    http://bit.ly/1TwB8Zj
  • Gómez-Dantés, Héctor; Lamadrid-Figueroa, Héctor; Cahuana-Hurtado, Lucero; Silverman-Retana, Omar; Montero, Pablo; González-Robledo, María Cecilia; et al. The burden of cancer in Mexico, 1990-2013. Salud pública Méx 2016, vol.58, n.2, pp.118-131.
    http://bit.ly/1WfmrA2
  • González-León M, Fernández-Gárate JE, Rascón-Pacheco RA, Valladares-Aranda MA, Dávila-Torres J, Borja-Aburto VH. The burden of disease of cancer in the Mexican Social Security Institute. Salud Publica Mex 2016;58:132-141.
    http://bit.ly/1VO5sEV
  • Hernández-Ávila JE, Palacio-Mejía LS, González-González L, Morales-Carmona E, Espín-Arellano LI, Fernández-Niño JA, Mohar-Betancourt A, Hernández-Avila M. Utilization of hospital services for cancer care in Mexico. Salud Publica Mex 2016;58:142-152.
    http://bit.ly/1rA7MTu
  • Borja-Aburto VH, Dávila-Torres J, Rascón-Pacheco RA, González-León M, Fernández-Gárate JE, Mejía-Rodríguez I, González-Izquierdo JJ, Escudero-de los Ríos PM. Cancer mortality in the Mexican Institute of Social Security, 1989-2013. Salud Publica Mex 2016;58:153-161.
    http://bit.ly/21Idwa9
  • Ventura-Alfaro CE, Torres-Mejía G, Ávila-Burgos LS. Hospitalization and mortality in Mexico due to breast cancer since its inclusion in the catastrophic expenditures scheme. Salud Publica Mex 2016;58:187-196.
    http://bit.ly/1TuURs4
  • Pineda-Belmontes CP, Hernández-Ramírez RU, Hernández-Alcaraz C, Cebrián ME, López-Carrillo L. Genetic polymorphisms of PPAR gamma, arsenic methylation capacity and breast cancer risk in Mexican women. Salud Publica Mex 2016;58:220-227.
    http://bit.ly/1TuV3aC
  • Gutiérrez-Delgado C, Armas-Texta D, Reynoso-Noverón N, Meneses-García A, Mohar-Betancourt A. Estimating the indirect costs associated with the expected number of cancer cases in Mexico by 2020. Salud Publica Mex 2016;58:228-236.
    http://bit.ly/1O6r8JK
  • Ángeles-Llerenas A, Torres-Mejía G, Lazcano-Ponce E, Uscanga-Sánchez S, Mainero-Ratchelous F,
    Hernández-Ávila JE, Morales-Carmona E, Hernández-Ávila M. Effect of care-delivery delays on the survival of Mexican women with breast cancer.  Salud Publica Mex 2016;58:237-250.
    http://bit.ly/1SWGY6I
  • Stepien M, Chajes V, Romieu I. The role of diet in cancer: the epidemiologic link. Salud Publica Mex 2016;58:261-273.
    http://bit.ly/1ZqXkZ2
  • Leal YA, Fernández-Garrote LM, Mohar-Betancourt A, Meneses-García A. The importance of registries in cancer control. Salud Publica Mex 2016;58:309-316.
    http://bit.ly/1YeWNsR
  • Reynoso-Noverón N, Meneses-García A, Erazo-Valle A, Escudero-de los Ríos P, Kuri-Morales PA, Mohar-Betancourt A. Challenges in the development and implementation of the National Comprehensive Cancer Control Program in Mexico. Salud Publica Mex 2016;58:325-333.
    http://bit.ly/1TNwf0J

Abril, 2016

  • Langton JM, Reeve R, Srasuebkul P, Haas M, Viney R, Currow D, Pearson SA.  Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective. Br J Cancer advance online publication, 2016; doi:10.1038/bjc.2016.75
    http://bit.ly/1QG1PZF
  • Editorial. Improved drug access in low and middle-income countries. The Lancet Oncology 2016; DOI: http://dx.doi.org/10.1016/S1470-2045(16)30068-7
    http://bit.ly/1SByCEG
  • Editorial. Impact of Brexit on cancer care and research. The Lancet Oncology 2016; DOI: http://dx.doi.org/10.1016/S1470-2045(16)30025-0
    http://bit.ly/1TCcA3C
  • Comment. Massimo Cristofanilli. Inflammatory breast cancer: a new approach. The Lancet Oncology 2016; DOI: http://dx.doi.org/10.1016/S1470-2045(16)00064-4
    http://bit.ly/21m8bVG
  • Christine Ecclestone, Ronald Chow, Natalie Pulenzas, Liying Zhang, Angela Leahey, Julia Hamer, Carlo DeAngelis, Gillian Bedard, Rachel McDonald, Anchal Bhatia, Janet Ellis, Eileen Rakovitch, Sherlyn Vuong, Edward Chow , Sunil Verma. Quality of life and symptom burden in patients with metastatic breast cancer. Supportive Care in Cancer 2016; DOI 10.1007/s00520-016-3217-z
    http://bit.ly/1VZquQE
  • Editorial. Martins T, Hamilton W. The influence of ethnicity on diagnosis of cancer. Family Practice 2016; doi:10.1093/fampra/cmw027
    http://bit.ly/26F0oWU
  • Krishnamurthy A, Soundara V, Ramshankar V. Preventive and Risk Reduction Strategies for Women at High Risk of Developing Breast Cancer: a Review. Asian Pac J Cancer Prev. 2016;17(3):895-904.
    http://bit.ly/247JOwH
  • Romeiro Lopes TC, Franca Gravena AA, Demitto Mde O, Brischiliari SC, Borghesan DH, Dell Agnolo CM, Carvalho MD, Pelloso SM. Mammographic Screening of Women Attending a Reference Service Center in Southern Brazil. Asian Pac J Cancer Prev. 2016;17(3):1385-91.
    http://bit.ly/1Tn1cIO
  • Rafiemanesh H, Salehiniya H, Lotfi Z. Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends. Asian Pac J Cancer Prev. 2016;17(3):1393-7.
    http://bit.ly/1NFpZU2
  • Al-Sakkaf KA, Basaleem HO. Breast Cancer Knowledge, Perception and Breast Self- Examination Practices among Yemeni Women: an Application of the Health Belief Model. Asian Pac J Cancer Prev. 2016;17(3):1463-7.
    http://bit.ly/1pp8Yr7
  • Zahmatkesh B, Keramat A, Alavi N, Khosravi A, Kousha A, Motlagh AG, Darman M, Partovipour E, Chaman R. Breast Cancer Trend in Iran from 2000 to 2009 and Prediction till 2020 using a Trend Analysis Method. Asian Pac J Cancer Prev. 2016;17(3):1493-8.
    http://bit.ly/1qGo0tf
  • Kristina SA, Endarti D, Sendjaya N, Pramestuty O. Estimating the Burden of Cancers Attributable to Smoking Using Disability Adjusted Life Years in Indonesia. Asian Pac J Cancer Prev. 2016;17(3):1577-81.
    http://bit.ly/1NnVQh5
  • Viewpoint. Corley DA, Haas JS, Kobrin S. Reducing Variation in the “Standard of Care” for Cancer Screening Recommendations From the PROSPR Consortium. JAMA 2016; doi:10.1001/jama.2016.3067
    http://bit.ly/1VqbTxR
  • Greenlee H, Molmenti CL, Crew KD, Awad D, Kalinsky K, Brafman L, Fuentes D, Shi Z, Tsai WY, Neugut AI, Hershman DL. Survivorship care plans and adherence to lifestyle recommendations among breast cancer survivors. J Cancer Surviv. 2016 DOI 10.1007/s11764-016-0541-8
    http://bit.ly/1NFyL4j
  • Lydia E. Pace, Lawrence N. Shulman. Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality. The Oncologist 2016; doi:10.1634/theoncologist.2015-0429
    http://bit.ly/1pr9lBp
  • Barbara Więckowska, Andrzej Tolarczyk, Janusz Dagiel. Cancer care in Poland: activity and spending analysis as a forerunner to oncology reform. Journal of Cancer Policy 2016; DOI: http://dx.doi.org/10.1016/j.jcpo.2016.03.003
  • Ping-Ping Bao, Ying Zheng, Chun-Xiao Wu, Zhe-Zhou Huang, Yu-Tang Gao, Fan Jin, Yong-Bing Xiang, Wei-Jian Zhong, Wei Lu, Fan Wu. Cancer incidence in urban Shanghai, 1973-2010: an updated trend and age-period-cohort effects. BMC Cancer 2016; DOI: 10.1186/s12885-016-2313-2
    http://bit.ly/216dyIp
  • Mauro Laudicella, Brendan Walsh, Elaine Burns and Peter C Smith. Cost of care for cancer patients in England: evidence from population-based patient-level data. Br J Cancer 2016; doi:10.1038/bjc.2016.77
    http://bit.ly/22zzHhB
  • Nils G. Bjurstam, Lena M. Björneld and Stephen W. Duffy. Updated results of the Gothenburg Trial of Mammographic Screening. Cancer 2016, DOI: 10.1002/cncr.29975
    http://bit.ly/1SPTjJe
  • Dilshad Kassam, Nicole S. Berry & Jaffer Dharsee. Transforming breast cancer control campaigns in low and middle-income settings: Tanzanian experience with ‘Check It, Beat It’.  Global Public Health 2016, DOI: 10.1080/17441692.2016.1170182
    http://bit.ly/1T9p2ru
  • Segnan N, Minozzi S, Armaroli P, Cinquini M, Bellisario C, González-Lorenzo M, Gianola S, Ponti A. Epidemiologic evidence of slow growing, non-progressive or regressive breast cancer: a systematic review. Int J Cancer. 2016; doi: 10.1002/ijc.30105
    http://bit.ly/1RYUM3v
  • Shi-Yi Wang, Sylvia H. Hsu, Cary P. Gross, Tara Sanft, Amy J. Davidoff, Xiaomei Ma, James B. Yu. Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis
    http://bit.ly/1SHLMf8
  • K.M. Almutairi, E.A. Mansour, J.M. Vinluan. A cross-sectional assessment of quality of life of breast cancer patients in Saudi Arabia. Public Health 2016; DOI: http://dx.doi.org/10.1016/j.puhe.2016.03.008
    http://bit.ly/1r0DysD
  • Rakkapao N, Promthet S, Moore MA, Hurst CP. Development of a Breast Cancer Awareness Scale for Thai Women: Moving towards a Validated Measure. Asian Pac J Cancer Prev. 2016;17(2):851-6.
    http://bit.ly/1UZEEQn
  • Chong VH, Telisinghe PU, Lim E, Tan J, Chong CF. Cancers among South-East Asian Nationals in Brunei Darussalam. Asian Pac J Cancer Prev. 2016;17(2):845-9.
    http://bit.ly/22i5Fim
  • Boscoe FP, Henry KA, Sherman RL, Johnson CJ. The relationship between cancer incidence, stage and poverty in the United States. International Journal of Cancer 2016, DOI: 10.1002/ijc.30087
    http://bit.ly/1PZm6c3
  • Lu Yao, Jie Sun, Juan Zhang, Yingjian He, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie. Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations. Breast Cancer Research and Treatment 2016; DOI 10.1007/s10549-016-3766-3
    http://bit.ly/1RRKvow
  • Evans DG, Donnelly LS, Harkness EF, Astley SM, Stavrinos P, Dawe S, Watterson D, Fox L, Sergeant JC, Ingham S, Harvie MN, Wilson M, Beetles U, Buchan I, Brentnall AR, French DP, Cuzick J, Howell A. Breast cancer risk feedback to women in the UK NHS breast screening population. Br J Cancer advance online publication 2016; doi:10.1038/bjc.2016.56
    http://bit.ly/1RRIo0D
  • Sirpa Heinävaara, Tytti Sarkeala and Ahti Anttila. Impact of organised mammography screening on breast cancer mortality in a case–control and cohort study. Br J Cancer 2016; doi:10.1038/bjc.2016.68
    http://bit.ly/1RRIUvK
  • Kelly M. Trevino, Baohui Zhang, Megan J. Shen and Holly G. Prigerson. Accuracy of advanced cancer patients' life expectancy estimates: The role of race and source of life expectancy information. Cancer 2016; DOI: 10.1002/cncr.30001
    http://bit.ly/1VhBFT7
  • Möllerberg ML, Sandgren A, Lithman T, Noreen D, Olsson H, Sjövall K. The effects of a cancer diagnosis on the health of a patient's partner: a population-based registry study of cancer in Sweden. European Journal of Cancer Care 2016, DOI: 10.1111/ecc.12487
    http://bit.ly/1V0v9RT
  • Galán S, de la Vega R, Tomé Pires C, Racine M, Solé E, Jensen MP, Miró J. What are the needs of adolescents and young adults after a cancer treatment? A Delphi study Eur J Cancer Care (Engl). 2016 doi: 10.1111/ecc.12488
    http://bit.ly/1SIpwVd
  • Webber C, Jiang L, Grunfeld E, Groome PA. Identifying predictors of delayed diagnoses in symptomatic breast cancer: a scoping review. Eur J Cancer Care (Engl). 2016 doi: 10.1111/ecc.12483
    http://bit.ly/1MJywdn
  • Schindler M, Spycher BD, Ammann RA, Ansari M, Michel G, Kuehni CE; Swiss Paediatric Oncology Group (SPOG); Swiss Paediatric Oncology Group SPOG. Cause-Specific Long-Term Mortality in Survivors of Childhood Cancer in Switzerland: A Population Based Study. Int J Cancer. 2016 doi: 10.1002/ijc.30080
    http://bit.ly/1N3Kcmf
  • Shin DW, Cho J, Yang HK, Kim SY, Mok HK, Lee H, Park SM, Huh JS, Ryu J, Park JH. Attitudes towards second opinion services in cancer care: a nationwide survey of oncologists in Korea. Jpn. J. Clin. Oncol. 2016, doi:10.1093/jjco/hyw016
    http://bit.ly/1REsmrZ
  • Comment. Massimo Cristofanilli. Inflammatory breast cancer: a new approach. The Lancet 2016,
    DOI: http://dx.doi.org/10.1016/S1470-2045(16)00064-4
    http://bit.ly/1qnVRri
  • Chuang Chen, Si Sun, Jing-Ping Yuan, Yao-Huai Wang, Tian-Ze Cao, Hong-Mei Zheng, Xue-Qing Jiang, Yi-Ping Gong, Yi Tu, Feng Yao, Ming-Bai Hu, Juan-Juan Li, Sheng-Rong Sun, Wen Wei. Characteristics of breast cancer in Central China, literature review and comparison with USA. The breast 2016, doi:10.1016/j.breast.2016.01.004
     http://bit.ly/1UA09bx

Marzo, 2016

  • Hrishikesh P. Kale and Norman V. Carroll. Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer 2016; DOI: 10.1002/cncr.29808
    http://bit.ly/1Ra7BUG
  • Denise Riedel Lewis, Huann-Sheng Chen, Myles Cockburn, Xiao-Cheng Wu, Antoinette M. Stroup, Douglas N. Midthune, Martin F. Krapcho, Daniel G. Miller, Lynne Penberthy and Eric J. Feuer. Preliminary estimates of SEER cancer incidence for 2013. Cancer 2016; DOI: 10.1002/cncr.29953
    http://bit.ly/1XC2L6H
  • Tehranifar P, Goyal A, Phelan JC, Link BG, Liao Y, Fan X, Desai M, Terry MB. Age at cancer diagnosis, amenability to medical interventions, and racial/ethnic disparities in cancer mortality. Cancer Causes Control. 2016; doi: 10.1007/s10552-016-0729-2.
    http://bit.ly/1puoWQX
  • Brenner DR, Brockton NT, Kotsopoulos J, Cotterchio M, Boucher BA, Courneya KS, Knight JA, Olivotto IA, Quan ML, Friedenreich CM. Breast cancer survival among young women: a review of the role of modifiable lifestyle factors. Cancer Causes Control. 201; 6doi: 10.1007/s10552-016-0726-5.
    http://bit.ly/1nWEZG5
  • Youl PH, Dasgupta P, Youlden D, Aitken JF, Garvey G, Zorbas H, Chynoweth J, Wallington I, Baade PD. A systematic review of inequalities in psychosocial outcomes for women with breast cancer according to residential location and Indigenous status in Australia. Psychooncology 2016; DOI: 10.1002/pon.4124
    http://bit.ly/1puwqDq
  • Nipp RD, Lee H, Powell E, Birrer NE, Poles E, Finkelstein D, Winkfield K, Percac-Lima S, Chabner B, Moy B. Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program. The Oncologist 2016; doi:10.1634/theoncologist.2015-0481
    http://bit.ly/1R5cwtn
  • Mansha M, Saleem M, Wasim M, Tariq M. Prevalence of Known Risk Factors in Women Diagnosed with Breast Cancer at Inmol Hospital, Lahore, Punjab. Asian Pac J Cancer Prev. 2016;17(2):563-8.
    http://bit.ly/227dk8j
  • Zehtab N, Jafari M, Barooni M, Nakhaee N, Goudarzi R, Larry Zadeh MH. Cost-Effectiveness Analysis of Breast Cancer Screening in Rural Iran. Asian Pac J Cancer Prev. 2016;17(2):609-14.
    http://bit.ly/1QL0pjO
  • Lv YG, Huang ML, Xiao JJ, Ling R. Establishment and Clinical Application of an Electronic Database for Breast Cancer in China. Asian Pac J Cancer Prev. 2016;17(2):639-41.
    http://bit.ly/1UmsEYK
  • Shakeri J, Golshani S, Jalilian E, Farnia V, Nooripour R, Alikhani M, Yaghoobi K. Studying the Amount of Depression and its Role in Predicting the Quality of Life of Women with Breast Cancer. Asian Pac J Cancer Prev. 2016;17(2):643-6.
    http://bit.ly/1RVH3c1
  • Khokher S, Qureshi MU, Mahmood S, Sadiq S. Determinants of Advanced Stage at Initial Diagnosis of Breast Cancer in Pakistan: Adverse Tumor Biology vs Delay in Diagnosis. Asian Pac J Cancer Prev. 2016;17(2):759-65.
    http://bit.ly/1WfR7hd
  • Rakkapao N, Promthet S, Moore MA, Hurst CP. Development of a Breast Cancer Awareness Scale for Thai Women: Moving towards a Validated Measure. Asian Pac J Cancer Prev. 2016;17(2):851-6.
    http://bit.ly/1UZEEQn
  • Vetter L, Keller M, Bruckner T, Golatta M, Eismann S, Evers C, Dikow N, Sohn C, Heil J, Schott S. Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany. Breast Cancer Research and Treatment 2016; DOI 10.1007/s10549-016-3748-5
    http://bit.ly/1nDXoY2
  • Editorial. Otis W. Brawley. The cancer registry as a cancer-control tool. Cancer 2016; DOI: 10.1002/cncr.29968
    http://bit.ly/1RETCG4
  • News. Talha Khan Burki. Cost of unused cancer drugs in the USA. The Lancet Oncology 2016; DOI: http://dx.doi.org/10.1016/S1470-2045(16)00158-3
    http://bit.ly/1WgfRpJ
  • Shaneda Warren Andersen, William J. Blot, Xiao-Ou Shu, Jennifer S Sonderman, Mark D Steinwandel, Margaret K. Hargreaves, and Wei Zheng. Adherence to cancer prevention guidelines and cancer risk in low-income and African American populations. Cancer Epidemiol Biomarkers Prev 2016; doi:10.1158/1055-9965.EPI-15-1186
    http://bit.ly/224oU3U
  • J. Li, J. Holm, J. Bergh, M. Eriksson, H. Darabi, L. S. Lindström, S. Törnberg, P. Hall, and K. Czene. Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers. Ann Oncol. 2016; doi:10.1093/annonc/mdw096
    http://bit.ly/1pqPEu0
  • Williams DR, Mohammed SA, Shields AE. Understanding and effectively addressing breast cancer in African American women: Unpacking the social context. Cancer 2016; DOI: 10.1002/cncr.29935
    http://bit.ly/21cASTi
  • Adam M, Rueegg CS, Schmidlin K, Spoerri A, Niggli F, Grotzer M, von der Weid NX, Egger M, Probst-Hensch N, Zwahlen M, Kuehni CE and for the Swiss Paediatric Oncology Group (SPOG) and the Swiss National Cohort Study (SNC). Socioeconomic disparities in childhood cancer survival in Switzerland. Int. J. Cancer. 2016; DOI: 10.1002/ijc.30029
    http://bit.ly/1QwQHCX
  • Editorial. Perceptions of cancer in society must change. The Lancet Oncology 2016; DOI: http://dx.doi.org/10.1016/S1470-2045(16)00091-7
    http://bit.ly/1LZo1gr
  • Comment. Peter Littlejohns, Albert Weale, Katharina Kieslich, James Wilson, Benedict Rumbold, Catherine Max, Annette Rid. Challenges for the new Cancer Drugs Fund. The Lancet Oncology 2016; DOI: http://dx.doi.org/10.1016/S1470-2045(16)00100-5
    http://bit.ly/24HgBdh
  • Crochet P, Molinari N, Darmon JC, Cutuli B, Serin D. Follow-up of Patients Treated for pT1aN0M0 Breast Cancer: 10-year Survival and Prognostic Factors. The Breast Journal 2016; DOI: 10.1111/tbj.12587
    http://bit.ly/1oXA6xg
  • Mayne K and Adamson D. Acceptance and Adherence of Endocrine Therapy in Women with Metastatic Breast Cancer: Is Parenteral Treatment Effective? The Breast Journal 2016;  DOI: 10.1111/tbj.12588
    http://bit.ly/1UHiySs
  • Vicini F, Shah C and Arthur D. The Increasing Role of Lymphedema Screening, Diagnosis and Management as Part of Evidence-Based Guidelines for Breast Cancer Care. The Breast Journal 2016;  DOI: 10.1111/tbj.12586
    http://bit.ly/1L83mvY
  • Sebastien Antoni, Isabelle Soerjomataram, Bjørn Møller, Freddie Bray & Jacques Ferlay. An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence. Bull WHO 2016; http://dx.doi.org/10.2471/BLT.15.164384
    http://bit.ly/1RNbq4p
  • C. Ortega–Olvera, G. Torres–Mejía, L.M. Sánchez–Zamorano, A. Ángeles–Llerenas, L. Martínez–Matsushita, R. Rojas–Martínez, E. Montemayor–Varela, Edgar Navarro-Lechuga, E. Lazcano–Ponce. Knowledge and recommendations regarding breast cancer early screening in an upper middle income country: Primary and secondary health care professionals. Preventive Medicine 2016; doi:10.1016/j.ypmed.2016.02.041
    http://bit.ly/1Ru08Q3
  • Karlsen RV, Frederiksen K, Larsen MB, von Heymann-Horan AB, Appel CW, Christensen J, Tjønneland A, Ross L, Johansen C, Bidstrup PE. The impact of a breast cancer diagnosis on health-related quality of life. A prospective comparison among middle-aged to elderly women with and without breast cancer. Acta Oncologica 2016; DOI:10.3109/0284186X.2015.1127415
    http://bit.ly/1Tyn9aD

Febrero. 2016

  • Kim YJ, Park MS, Lee E, Choi JW. High Incidence of Breast Cancer in Light-Polluted Areas with Spatial Effects in Korea. Asian Pac J Cancer Prev. 2016;17(1):361-7.
    http://bit.ly/1KQdYiM
  • Horii R, Honma N, Ogiya A, Kozuka Y, Yoshida K, Yoshida M, Horiguchi SI, Ito Y, Mukai H. The Japanese Breast Cancer Society clinical practice guidelines for pathological diagnosis of breast cancer, 2015 edition. Breast Cancer. 2016 DOI:10.1007/s12282-016-0675-6
    http://bit.ly/21wPJdy
  • Aihara T, Toyama T, Takahashi M, Yamamoto Y, Hara F, Akabane H, Fujisawa T, Ishikawa T, Nagai S, Nakamura R, Tsurutani J, Ito Y, Mukai H. The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer, 2015 edition. Breast Cancer. 2016 DOI:10.1007/s12282-016-0670-y
    http://bit.ly/1LijYRe
  • Sujin Kim and Jongnam Hwang. Assessment of trends in socioeconomic inequalities in cancer screening services in Korea, 1998–2012. International Journal for Equity in Health 2016 15:30
    http://bit.ly/21mQCbL
  • Shoemaker ML, White MC. Breast and cervical cancer screening among Hispanic subgroups in the USA: estimates from the National Health Interview Survey 2008, 2010, and 2013. Cancer Causes Control. 2016; DOI 10.1007/s10552-016-0718-5
    http://bit.ly/1Q5uiw9
  • Weir HK, Johnson CJ, Ward KC, Coleman MP.The effect of multiple primary rules on cancer incidence rates and trends. Cancer Causes Control. 2016;
    http://bit.ly/1Ucbw84
  • E. Kilsdonk, E. Wendel, E. van Dulmen-den Broeder, F.E. van Leeuwen, M.H. van den Berg and M.W. Jaspers. Participation rates of childhood cancer survivors to self-administered questionnaires: a systematic review. 2016; European Journal of Cancer Care 2016; DOI: 10.1111/ecc.12462
    http://bit.ly/1VsdrUz
  • Holly R. Harris, Leif Bergkvist and Alicja Wolk. Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and breast cancer risk. International Journal of Cancer 2016; DOI: 10.1002/ijc.30015
    http://bit.ly/1RTkVAT
  • Laura M. Woods, Bernard Rachet, Dianne O'Connell, Gill Lawrence and Michel P. Coleman. Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997–2006. International Journal of Cancer 2016; DOI: 10.1002/ijc.29983
    http://bit.ly/1oa0ROG
  • KiSook Kim and Ji-Su Kim. Factors influencing health-related quality of life among Korean cancer survivors. Psycho-Oncology, doi: 10.1002/pon.4105.
    http://bit.ly/1TqN5TQ
  • Yamile Molina, Ashley Scherman, Tara Hayes Constant, Bridgette Hempstead, Jacci Thompson-Dodd, Shayla Richardson, Shauna Rae Weatherby, Kerryn W. Reding, Rachel M. Ceballos. Medical advocacy among African-American women diagnosed with breast cancer: from recipient to resource. Supportive Care in Cancer 2016; DOI: 10.1007/s00520-016-3123-4
    http://bit.ly/1PMbCQS
  • Yan Yuan, Maoji Li, Jing Yang, Tracy Elliot, Kelly Dabbs, James A. Dickinson, Stacey Fisher and Marcy Winget. Factors related to breast cancer detection mode and time to diagnosis in Alberta, Canada: a population-based retrospective cohort study. BMC Health Services Research 2016 16:65
    http://bit.ly/213WqXF
  • Sanjeewa Seneviratne , Ross Lawrenson, Vernon Harvey, Reena Ramsaroop, Mark Elwood, Nina Scott, Diana Sarfati, Ian Campbell. Stage of breast cancer at diagnosis in New Zealand: impacts of socio-demographic factors, breast cancer screening and biology. BMC Cancer 2016, DOI: 10.1186/s12885-016-2177-5
    http://bit.ly/1QPqECT
  • G. Teskereci and O. Kulakaç. Life experiences of caregivers of women with gynaecological cancer: a mixed-methods systematic review. European Journal of Cancer Care 2016; DOI: 10.1111/ecc.12456
    http://bit.ly/1QdWuJ7
  • A. Gorini, M. Masiero and G. Pravettoni. Patient decision aids for prevention and treatment of cancer diseases: are they really personalised tools?. European Journal of Cancer Care 2016; DOI: 10.1111/ecc.12451
    http://bit.ly/211cIgr
  • J.N.W. Lim and A.A. Ojo. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. European Journal of Cancer Care 2016; DOI: 10.1111/ecc.12444
    http://bit.ly/211cVAa
  • Laura M. Woods, Bernard Rachet, Dianne O'Connell, Gill Lawrence and Michel P. Coleman. Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997–2006. Cancer Epidemiology 2016; DOI: 10.1002/ijc.29983
    http://bit.ly/1oa0ROG
  • Cheung SY, Delfabbro P. Are you a cancer survivor? A review on cancer identity. Journal of Cancer Survivorship 2016; DOI 10.1007/s11764-016-0521-z              
     http://bit.ly/1PTsiXM
  • Pérez-Zepeda MU, Cárdenas-Cárdenas E, Cesari M, Navarrete-Reyes AP, Gutiérrez-Robledo LM. Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study. J Cancer Surviv. 2016; DOI 10.1007/s11764-016-0519-6
    http://bit.ly/1Qe1PQq
  • Gordon C Jayson, Robert Kerbel, Lee M Ellis, Adrian L Harris. Antiangiogenic therapy in oncology: current status and future directions. The Lancet 2016;  DOI: http://dx.doi.org/10.1016/S0140-6736(15)01088-0
    http://bit.ly/1Qe4gTc
  • NEWS. Talha Khan Burki. Oncologic Drugs Advisory Committee and conflicts of interest. The Lancet Onclogy 2016;  DOI: http://dx.doi.org/10.1016/S1470-2045(16)00088-7
    http://bit.ly/1Qe5pu1
  • Comment. Hope S Rugo, A Jo Chien. HER2-positive breast cancer: is more treatment better? The Lancet Onclogy 2016; DOI: http://dx.doi.org/10.1016/S1470-2045(15)00623-3
    http://bit.ly/1R1xA2D
  • Adriana Pérez-Fortis, Maya J. Schroevers, Joke Fleer, Patricia Alanís-López, María Guadalupe Veloz-Martínez, Rosa Elena Ornelas-Mejorada, Robbert Sanderman, Adelita V. Ranchor and Juan José Sánchez Sosa. Psychological burden at the time of diagnosis among Mexican breast cancer patients. Psycho-Oncology 2016; DOI: 10.1002/pon.4098
    http://bit.ly/1Soi1VN
  • Azevedo E Silva G, de Moura L, Curado MP, Gomes Fda S, Otero U, Rezende LF, Daumas RP, Guimarães RM, Meira KC, Leite Ida C, Valente JG, Moreira RI, Koifman R, Malta DC, Mello MS, Guedes TW, Boffetta P. The Fraction of Cancer Attributable to Ways of Life, Infections, Occupation, and Environmental Agents in Brazil in 2020. PLoS One. 2016 Feb 10;11(2):e0148761.
    http://bit.ly/1WjJiH8
  • Fariba Farhadifar, Yamile Molina, Parvaneh Taymoori , Setareh Akhavan. Mediators of repeat mammography in two tailored interventions for Iranian women. BMC Public Health 2016; 16:149
    http://bit.ly/1XqgY7d
  • Jason D. Wright, Ling Chen, Ana I. Tergas, Melissa Accordino, Cande V. Ananth, Alfred I. Neugut, Dawn L. Hershman. Underuse of BRCA Testing in Patients with Breast and Ovarian Cancer. American Journal of Obstetrics and Gynecology 2016; doi:10.1016/j.ajog.2016.02.011
    http://bit.ly/1TfrOfF
  • Paolo V, De Lorenzi Francesca, Pietro L, Mario R, Umberto V. Current Trends in the Oncologic and Surgical Managements of Breast Cancer in Women with Implants: Incidence, Diagnosis, and Treatment. Aesthetic Plast Surg. 2016; DOI 10.1007/s00266-016-0612-2
    http://bit.ly/1oaxJHg
  • News. Richard Sullivan & Ajay Aggarwal. Health policy: Putting a price on cancer. Nature Reviews Clinical Oncology 2016; doi:10.1038/nrclinonc.2016.12
    http://bit.ly/1oe9yIn
  • Mette L Lousdal, Ivar S Kristiansen, Bjørn Møller and Henrik Støvring. Effect of organised mammography screening on stage-specific incidence in Norway: population study. Br J Cancer, 2016; doi:10.1038/bjc.2016.8
    http://bit.ly/20xXS4h
  • Ronald D. Barr, Lynn A. G. Ries, Denise R. Lewis, Linda C. Harlan, Theresa H. M. Keegan, Brad H. Pollock, W. Archie Bleyer and for the US National Cancer Institute Science of Adolescent and Young Adult Oncology Epidemiology Working Group. Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including “nonmalignant/noninvasive” tumors. Cancer 2016; DOI: 10.1002/cncr.29867
    http://bit.ly/20f0OgG
  • Theresa H.M. Keegan, Lynn A.G. Ries, Ronald D. Barr, Ann M. Geiger, Deborah Vollmer Dahlke, Bradley H. Pollock, Archie Bleyer and for the National Cancer Institute Next Steps for Adolescent and Young Adult Oncology Epidemiology Working Group. Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults. Cancer 2016; DOI: 10.1002/cncr.29869
    http://bit.ly/1S5TKDC
  • James V. Tricoli, Donald G. Blair, Carey K. Anders, Archie Bleyer, Lisa A. Boardman, Javed Khan, Shivaani Kummar, Brandon Hayes-Lattin, Stephen P. Hunger, Melinda Merchant, Nita L. Seibel, Magdalena Thurin and Cheryl L. Willman. Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma. Cancer 2016; DOI: 10.1002/cncr.29871
    http://bit.ly/1PceG8z
  • Pascal Jean-Pierre, Ying Cheng, Kristen J. Wells, Karen M. Freund, Frederick R. Snyder, Kevin Fiscella, Alan E. Holden, Electra D. Paskett, Donald J. Dudley, Melissa A. Simon, Patricia A. Valverde and Patient Navigation Research Program. Satisfaction with cancer care among underserved racial-ethnic minorities and lower-income patients receiving patient navigation. Cancer 2016; DOI: 10.1002/cncr.29902
    http://bit.ly/1odzFit
  • Comment. Franco Cavalli. Tackling cancer: time for a global response. The Lancet 2016; DOI: http://dx.doi.org/10.1016/S0140-6736(16)00233-6
    http://bit.ly/20f8mzZ
  • Editorial. Liquid cancer biopsy: the future of cancer detection? The Lancet Oncology 2016; DOI: http://dx.doi.org/10.1016/S1470-2045(16)00016-4
    http://bit.ly/1QLFAVj
  • Hartmann LC, Lindor NM. The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer. N Engl J Med 2016; 374:454-468
    http://bit.ly/1R69568
  • Christine Eulenburg, Jennifer Schroeder, Nadia Obi, Judith Heinz, Petra Seibold, Anja Rudolph, Jenny Chang-Claude, and Dieter Flesch-Janys. A Comprehensive Multistate Model Analyzing Associations of Various Risk Factors With the Course of Breast Cancer in a Population-Based Cohort of Breast Cancer Cases. Am. J. Epidemiol. 2016, doi:10.1093/aje/kwv163
    http://bit.ly/1Uvwqgv
  • Lu D, Lu T, Stroh M, Graham RA, Agarwal P, Musib L, Li CC, Lum BL, Joshi A. A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities. Cancer Chemother Pharmacol. 2016 DOI 10.1007/s00280-015-2931-4
    http://bit.ly/1PK6S1h
  • Amori N, Aghajani M, Asgarian FS, Jazayeri M. Epidemiology and trend of common cancers in Iran (2004–2008).  Eur J Cancer Care 2016; DOI: 10.1111/ecc.12449
    http://bit.ly/1UvHryf
  • Passarelli MN, Newcomb PA, Hampton JM, Trentham-Dietz A, Titus LJ, Egan KM, Baron JA, Willett WC. Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases. JCO 2016; DOI:10.1200/JCO.2015.63.9328
    http://bit.ly/23yzVJa
  • Scott D. Ramsey, Aasthaa Bansal, Catherine R. Fedorenko, David K. Blough, Karen A. Overstreet, Veena Shankaran, and Polly Newcomb. Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer. JCO 2016; DOI:10.1200/JCO.2015.64.6620
    http://bit.ly/1nMNxQx
  • James TA, Wade JE, Sprague BL. The impact of mammographic screening on the surgical management of breast cancer. J. Surg. Oncol. 2016; doi: 10.1002/jso.24184
    http://bit.ly/23kkNPx
  • NEWS Sanjay Tanday. Framework for tackling paediatric chemotherapy drug shortages. The Lancet Oncology 2016; DOI: http://dx.doi.org/10.1016/S1470-2045(16)00071-1
    http://bit.ly/1SpoSN5
  • NEWS Michael Granovetter. Inadvisable breast and prostate cancer screenings in the USA. The Lancet Oncology 2016; DOI: http://dx.doi.org/10.1016/S1470-2045(16)00069-3
    http://bit.ly/1JMZvn6
  • Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens AC, Stovall M, Oeffinger KC, Bhatia S, Krull KR, Nathan PC, Neglia JP, Green DM, Hudson MM, Robison LL. Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. N Engl J Med.
    http://bit.ly/1Q0IzJ6

Enero, 2016

  • Comment. Tito Fojo, Andrew W Lo. Price, value, and the cost of cancer drugs. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(15)00564-1
    http://bit.ly/22zFdn3
  • Chloe M. Chhor, Cecilia L. Mercado. Integrating Customer Intimacy Into Radiology to Improve the Patient Perspective: The Case of Breast Cancer Screening. American Journal of Roentgenology. 2016;206:265-269. 10.2214/AJR.15.15459
    http://bit.ly/1S9ZR8G
  • D. Hashim, P. Boffetta, C. La Vecchia, M. Rota, P. Bertuccio, M. Malvezzi, and E. Negri. The global decrease in cancer mortality: trends and disparities. Ann Oncol 2016; doi:10.1093/annonc/mdw027
    http://bit.ly/1Jq8sCR
  • Viewpoint. Lin KW, Gostin LO. A Public Health Framework for Screening Mammography: Evidence-Based vs Politically Mandated Care. JAMA. 2016; doi: 10.1001/jama.2016.0322
    http://bit.ly/1PBy3oO
  • Henson KE, Jagsi R, Cutter D, McGale P, Taylor C, Darby SC. Inferring the Effects of Cancer Treatment: Divergent Results From Early Breast Cancer Trialists’ Collaborative Group Meta-Analyses of Randomized Trials and Observational Data From SEER Registries. JCO, 2016; DOI:10.1200/JCO.2015.62.0294
    http://bit.ly/1RAf83N
  • Colleoni M, Sun Z, Price KN, Karlsson P, Forbes JF, Thürlimann B, Gianni L, Castiglione M, Gelber RD, Coates AS, Goldhirsch A. Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V. J Clin Oncol. 2016 Jan 19. pii: JCO623504.
    http://bit.ly/1UhgbDB
  • Correspondence. Lisa A. Newman. Parsing the Etiology of Breast Cancer Disparities. JCO, 2016; DOI:10.1200/JCO.2015.65.1877.
    http://bit.ly/1ZI3DXg
  • Fardell JE, Thewes B, Turner J, Gilchrist J, Sharpe L, Smith A', Girgis A, Butow P. Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation. J Cancer Surviv. 2016 DOI 10.1007/s11764-015-0512-5
    http://bit.ly/1nqXZNM
  • Ted A. James, Jacqueline E. Wade and Brian L. Sprague. The impact of mammographic screening on the surgical management of breast cancer. Journal of Surgical Oncology 2016, DOI: 10.1002/jso.24184
    http://bit.ly/23kkNPx
  • Comment. Martin J Yaffe, Roberta A Jong. Adjunctive ultrasonography in breast cancer screening. The Lancet 2016, DOI: http://dx.doi.org/10.1016/S0140-6736(15)00787-4
    http://bit.ly/1ODiLSN
  • News. Judith A Gilbert. Reducing treatment-related mortality in childhood cancers. The Lancet Oncology 2016, DOI: http://dx.doi.org/10.1016/S1470-2045(16)00031-0
    http://bit.ly/1OMiRFy
  • Sara Stulac, Richard B. Mark Munyaneza, Jeanne Chai, Jean Bosco Bigirimana, Merab Nyishime, Neo Tapela, Sara Chaffee, Leslie Lehmann and Lawrence N. Shulman. Initiating Childhood Cancer Treatment in Rural Rwanda: A Partnership-Based Approach. Pediatric Blood & Cancer 2016, DOI: 10.1002/pbc.25903
    http://bit.ly/1nEPa2s
  • Dvortsin E, Gout-Zwart J, Eijssen E-LM, van Brussel J, Postma MJ. Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast Cancer. PLoS ONE 2016;11(1): e0146551. doi:10.1371/journal.pone.0146551
    http://bit.ly/1S0pZo2
  • Kim CS, Vanture S, Cho M, Klapperich CM, Wang C, Huang FW. Awareness, Interest, and Preferences of Primary Care Providers in Using Point-of-Care Cancer Screening Technology. PLoS ONE 2016;11(1): e0145215. doi:10.1371/journal.pone.0145215
    http://bit.ly/1ZT5VbD
  • Hillary Topazian, Mishka Cira, Sanford M. Dawsey, Joseph Kibachio, Lillian Kocholla, Mary Wangai, Jack Welch, Makeda J. Williams, Kalina Duncan, Annette Galassi. Joining forces to overcome cancer: The kenya cancer research and control stakeholder program. Journal of Cancer Policy 2016; DOI: http://dx.doi.org/10.1016/j.jcpo.2015.12.001
    http://bit.ly/1neUCbS
  • V. Nadalin, J. Maher, C. Lessels, A. Chiarelli, N. Kreiger. Breast screening knowledge and barriers among under/never screened women. Public Health 2016; DOI: http://dx.doi.org/10.1016/j.puhe.2015.11.028
    http://bit.ly/1lBUKRQ
  • My von Euler-Chelpin, Christina Bæksted, Ilse Vejborg & Elsebeth Lynge. Consequences of a false-positive mammography result: drug consumption before and after screening.  Acta Oncologica 2016; DOI:10.3109/0284186X.2015.1128120
    http://bit.ly/1OMwm8i
  • Maj-Britt Jensen, Bent Ejlertsen, Henning T. Mouridsen, Peer Christiansen & for the Danish Breast Cancer Cooperative Group. Improvements in breast cancer survival between 1995 and 2012 in Denmark: The importance of earlier diagnosis and adjuvant treatment. Acta Oncologica 2016; DOI:10.3109/0284186X.2015.1128119
    http://bit.ly/1ZIsXwh
  • Jeanette D. Jensen, Søren Cold, Mette H. Nielsen, Anne Marie B. Jylling, Katrine L. Søe, Lisbet B. Larsen, Marianne Ewertz & On behalf of the Academy of Geriatric Cancer Research (AgeCare). Trends in breast cancer in the elderly in Denmark, 1980–2012. Acta Oncologica 2016; DOI:10.3109/0284186X.2015.1115118
    http://bit.ly/23klkkr
  • Paul S, Solanki PP, Shahi UP, Srikrishna S. Epidemiological Study on Breast Cancer Associated Risk Factors and Screening Practices among Women in the Holy City of Varanasi, Uttar Pradesh, India. Asian Pac J Cancer Prev. 2015;16(18):8163-71.
    http://bit.ly/1SSTfMB
  • Lalitwongsa S, Pongnikorn D, Daoprasert K, Sriplung H, Bilheem S. Breast Cancer in Lampang, a Province in Northern Thailand: Analysis of 1993–2012 Incidence Data and Future Trends. Asian Pac J Cancer Prev, 2015;16 (18), 8327-8333
    http://bit.ly/1n7euhH
  • Sangkittipaiboon S, Leklob A, Sriplung H, Bilheem S. Breast Cancer in Lopburi, a Province in Central Thailand: Analysis of 2001–2010 Incidence and Future Trends. Asian Pac J Cancer Prev. 2015;16(18):8359-64.
    http://bit.ly/1n7eXjT
  • Ghoncheh M, Mirzaei M, Salehiniya H. Incidence and Mortality of Breast Cancer and their Relationship with the Human Development Index (HDI) in the World in 2012. Asian Pac J Cancer Prev. 2015;16(18):8439-43.
    http://bit.ly/1OnE4Yz
  • Abdullah MM, Mohamed AK, Foo YC, Lee CM, Chua CT, Wu CH, Hoo L, Lim TO, Yen SW. Breast Cancer Survival at a Leading Cancer Centre in Malaysia. Asian Pac J Cancer Prev. 2015;16(18):8513-7.
    http://bit.ly/1RUBZWj
  • Baghestani AR, Moghaddam SS, Majd HA, Akbari ME, Nafissi N, Gohari K. Survival Analysis of Patients with Breast Cancer using Weibull Parametric Model. Asian Pac J Cancer Prev. 2015;16(18):8567-71.
    http://bit.ly/1OnEI8s
  • Marshall DC, Webb TE, Hall RA, Salciccioli JD, Ali R, Maruthappu M. Trends in UK regional cancer mortality 1991–2007. Br J Cancer 2016; doi:10.1038/bjc.2015.428
    http://bit.ly/1RUCYWB
  • James A. Lee, Charles S. Roehrig and Erin Duggan Butto. Cancer care cost trends in the United States: 1998 to 2012. Cancer 2016; DOI: 10.1002/cncr.29883
    http://bit.ly/1n1HIxO
  • Editorial. Saro H. Armenian and Smita Bhatia. Looking back to inform the future: Lesson learned from survivors of childhood cancer. Cancer 2016; DOI: 10.1002/cncr.29703
    http://bit.ly/1RqS8UM
  • Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016 Jan 12. doi: 10.7326/M15-0969
    http://bit.ly/1np1gwB
  • Nelson HD, Pappas M, Cantor A, Griffin J, Daeges M, Humphrey L. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016 Jan 12. doi: 10.7326/M15-097
    http://bit.ly/1lguvju
  • Editorial. Laine C, Dickersin K, Mulrow C. Time to Douse the Firestorm Around Breast Cancer Screening. Ann Intern Med. 2016 Jan 12. doi: 10.7326/M15-2978.
    http://bit.ly/1QcmNUy
  • Editorial. Siu AL, Bibbins-Domingo K, Grossman DC, LeFevre ML; U.S. Preventive Services Task Force. Convergence and Divergence Around Breast Cancer Screening. Ann Intern Med. 2016 Jan 12. doi: 10.7326/M15-3065.
    http://bit.ly/1OnN0NC
  • Miglioretti DL, Lange J, van den Broek JJ, Lee CI, van Ravesteyn NT, Ritley D, Kerlikowske K, Fenton JJ, Melnikow J, de Koning HJ, Hubbard RA. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. Ann Intern Med. 2016 Jan 12. doi: 10.7326/M15-1241.
    http://bit.ly/1ZCkFeL
  • Mandelblatt JS, Stout NK, Schechter CB, van den Broek JJ, Miglioretti DL, Krapcho M, Trentham-Dietz A, Munoz D, Lee SJ, Berry DA, van Ravesteyn NT, Alagoz O, Kerlikowske K, Tosteson AN, Near AM, Hoeffken A, Chang Y, Heijnsdijk EA, Chisholm G, Huang X, Huang H, Ergun MA, Gangnon R, Sprague BL, Plevritis S, Feuer E, de Koning HJ, Cronin KA. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Ann Intern Med. 2016 Jan 12. doi: 10.7326/M15-1536.
    http://bit.ly/1PwZ90c
  • Editorial. Autier P. Efficient Treatments Reduce the Cost-Efficiency of Breast Cancer Screening. Ann Intern Med. 2016 Jan 12. doi: 10.7326/M15-2789.
    http://bit.ly/1UWfqQy
  • Nikolaos Diamantis and Udai Banerji. Antibody-drug conjugates—an emerging class of cancer treatment. Br J Cancer, 2016; doi:10.1038/bjc.2015.435
    http://bit.ly/1RyKfuW
  • Mogensen H, Modig K, Tettamanti G, Talbäck M, Feychting M. Socioeconomic differences in cancer survival among Swedish children. Br J Cancer, 2016; doi:10.1038/bjc.2015.449
    http://bit.ly/1S8WuzW
  • Marianne J. Heins, Joke C. Korevaar, Petra E.P.C. Hopman, Gé A. Donker, François G. Schellevis and Mieke P.M. Rijken. Health-related quality of life and health care use in cancer survivors compared with patients with chronic diseases. Article first published online: 7 JAN 2016 | DOI: 10.1002/cncr.29853
    http://bit.ly/22Qq0OJ